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ABSTRACT
The MarR family of transcriptional regulators comprises a subset of winged helix DNA-
binding proteins and includes numerous members that function in environmental surveillance of
aromatic compounds. This study presents a biochemical characterization of a novel MarR
homolog, HucR (hypothetical uricase regulator), from the DNA damage-resistant eubacterium,
Deinococcus radiodurans.
Circular dichroism spectroscopy suggests that HucR has ∼47% α-helix and 10% β-strand
conformation at 25°C, and undergoes a transition to a disordered state with Tm = 51.1 ± 0.0°C.
HucR binds as a homodimer with high sequence-specificity to a single site in its promoter region
(hucO) with an apparent Kd = 0.29 ± 0.02 nM. DNaseI and hydroxyl-radical footprinting indicate
HucR binding site sizes of ∼24 bp and 21 bp, respectively. The binding site contains a
pseudopalindromic sequence comprised of 8 bp inverted repeats separated by 2 bp that overlaps
predicted promoter elements for hucR and a putative uricase (dr1160). Specific phenolic weak
acids, notably uric acid, antagonize HucR-hucO complex formation. In vivo, uric acid increases
transcript levels of hucR and dr1160, ∼1.6-fold, and stimulates uricase activity 1.5-fold.
HucR-hucO complex formation involves protein conformational changes and a decrease
in the helical twist of the DNA duplex. Intrinsic fluorescence measurements show that uric acid
induces HucR conformational changes, and its apparent Kd = 11.6 ± 3.7 µM and Hill coefficient
of 0.7 ± 0.1 suggest negative cooperativity. An amino acid substitution in the predicted HucR
wing (HucR-R118A) reduces DNA-binding affinity ∼5-fold (Kd = 1.60 ± 0.14 nM), whereas a
substitution in the predicted recognition helix (HucR-S104A) does not significantly alter DNA-
binding affinity (Kd = 0.23 ± 0.03 nM). Each mutation decreases complex stability on the gel, but
does not affect sequence-specificity. Intrinsic fluorescence spectra suggest altered conformations
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of the HucR-variants and altered mechanisms of DNA association. The mutations at HucR
positions 118 and 104 also alter a predicted weak ligand-binding site, as indicated by minor
changes in uric acid affinities for HucR-R118A and HucR-S104A (Kd = 9.7 ± 3.2 µM and 7.4 ±




It has been suggested that approximately 6 – 7% of a eukaryotic genome, and 2 – 3% of a
prokaryotic genome encodes DNA-binding proteins (1). However, up to 10% of the genome of a
bacterial species capable of surviving exposure to a variety of environmental conditions may
encode regulators of gene expression (2). There are multiple systems of classification for DNA-
binding proteins, however, several major families may be identified by sequence and structural
similarities in the motifs used for DNA recognition, including the helix-turn-helix (HTH),
homeodomain, zinc finger, steroid receptor, leucine zipper, helix-loop-helix, and β-ribbon
proteins (1, 3). NMR and crystal structure analysis of prokaryotic transcriptional regulators has
revealed three recurrent DNA-binding motifs, namely the β-ribbon, HTH, and winged helix
motifs (4). The winged helix DNA-binding proteins comprise a subset of the HTH proteins and
the winged helix structure is strikingly the most abundant DNA-binding motif in the
transcription factors of bacteria and archaea (2). Based upon the wide distribution of winged
helix DNA-binding proteins amongst bacterial and archaeal genomes, this structure has been
suggested to be the earliest HTH motif to have evolved (2). The MarR (multiple antibiotic
resistance regulator) family of prokaryotic transcriptional regulators is one of nine families of
winged helix transcriptional regulators suggested to have existed in the common ancestor that
preceded the evolutionary split of archaea and bacteria ∼3.5 billion years ago (1, 2, 5).
Helix-Turn-Helix DNA-Binding Proteins and Discovery of the Winged Helix Motif
Structural determination of the HTH motif was first accomplished for the λ Cro and
Escherichia coli CAP proteins (6-8). The structures of numerous HTH proteins, free and
complexed with DNA, have since been solved at high resolution, revealing general features of
2this DNA-binding motif. As the name suggests, the HTH motif consists of two α-helices
separated by a turn, but the HTH motif by itself is not a stable, functional domain, but rather
exists in the context of a larger DNA-binding domain. The prototypical HTH motif is roughly 20
– 21 amino acids in length, with the first helix averaging seven residues and the second helix
(often called the “DNA-recognition helix”), averaging nine residues. The two α-helices are
generally separated by a 3 – 4 amino acid β-turn (Fig. 1.1). There is a strong conservation of
residues at certain positions in the HTH motif (9).  In the first helix of the motif, a hydrophobic
residue generally occupies the fourth position and the fifth position is often a residue with a
small side chain, such as glycine or alanine, due to steric considerations with the recognition
helix. In the turn region, the first and third amino acids are usually hydrophobic, with a glycine at
the second position. The fourth and seventh residues in the DNA recognition helix are often
hydrophobic. As prolines disrupt α-helical secondary structure, prolines are invariably absent
from the interiors of both helices in the HTH motif (9, 11). The result of the conserved,
hydrophobic residues in the helices and turn, and the minimal variability in the length of the turn,
is that the axes of the two α-helices of the HTH motif are oriented at an angle of ∼120°, with
little variability observed between canonical HTH proteins.
Side chains from the DNA recognition helix have been shown to mediate hydrogen bonds
with both the nucleobases of the DNA duplex and with the phosphodiester backbone. In addition,
the DNA recognition helix has been shown to be stabilized on the double helix by hydrophobic
contacts with thymine methyl groups in the DNA major groove (3, 9). Side chains outside the
DNA recognition helix often are involved in stabilizing the protein-DNA complex. For example,
the first helix of the HTH motif in λ repressor mediates a hydrogen bond with the DNA sugar-
phosphate backbone, and the first helix of a HTH motif in the prd protein from Drosophila
3Fig. 1.1  Prototypical helix-turn-helix DNA-binding motif. The HTH motif of the trp repressor
from E. coli bound to its sequence-specific DNA-binding site (blue). The first helix of the motif
is colored green (with the amino-terminal end designated by “N”) and the turn colored yellow.
The DNA-recognition helix (red) is inserted into the major groove (10).
N
4makes extensive contacts with the phosphate backbone (12, 13). Additional contacts also exist
between the α-helices themselves, stabilizing their relative orientations and their respective
contacts with the DNA duplex. Furthermore, polypeptide backbone-, cation-, and water-mediated
(as seen for the trp repressor) contacts with the DNA are sometimes observed for HTH proteins
(1, 3, 10). Residues outside the HTH motif also contact the DNA and help anchor the HTH motif
in a specific orientation relative to the DNA duplex. For example, an N-terminal arm of the λ
repressor wraps around the DNA double helix and mediates contacts in the major groove of the
consensus binding half-site (12).
The DNA recognition helix usually tracks the DNA major groove such that the N-
terminal protein side chains are in closest contact with the nucleobases of the double helix. The
orientation of the recognition helical axis relative to the direction of the major groove varies,
such that the angle between the α-helical axis and the axis of the DNA duplex varies by at least
15° in each direction. The orientation of the recognition helix, determined by other structural
components in the protein, in addition to the actual amino acid sequence of the α-helix,
contributes to DNA sequence recognition. The N-terminus of the first α-helix of the HTH motif
often contacts the phosphodiester backbone, but lies above the DNA recognition helix and the
DNA duplex (3, 9).
Structural features of a DNA-binding protein form only part of the picture in analyzing
mechanisms of sequence specific DNA-binding: DNA sequence, conformation, and dynamics
are equally important. The patterns of hydrogen bond donors and acceptors presented in the
major and minor grooves are sequence specific, with each of the four base pairs forming a
distinctive pattern in the major groove, with considerably less variability in the minor groove
(14).  In addition, the conformation of the sugar-phosphate backbone is sequence dependent. As
5numerous DNA-binding proteins induce bends in the DNA duplex, flexibility of the DNA is a
critical determinant of binding affinities. In this regard, it has been shown that A-T steps
generally favor duplex bending toward the minor groove, whereas G-C steps favor bending
toward the major groove (9). Also, inter-base pair hydrogen bonding stabilizes high propeller
twist for AT base pairs when consecutive adenines occur on the same strand, with the result that
AT tracts have reduced conformational flexibility (15). Moreover, the average minor groove
width of 6 Å is reduced in sequences rich in AT base pairs (9).
Comparisons of HTH proteins from eukaryotic organisms with those of prokaryotes
reveal very little sequence similarity, despite the conservation of the HTH structure in their
DNA-binding domains (13, 16, 17). Eukaryotic proteins with HTH DNA-binding motifs are
usually classified by the structural domain containing the HTH motif (e.g. POU and
homeodomain families). Prokaryotic HTH proteins almost always bind as homodimers to a
palindromic, or pseudopalindromic, DNA recognition sequence, such that the DNA recognition
helices from each half of the dimer bind the symmetric DNA half-sites within the major groove
of the duplex. There are exceptions to this rule: for example, proteins from the AraC family,
including MarA and Rob, bind as monomers via two HTH motifs to sequence specific DNA sites
(18-20).
Interest in winged helix proteins has increased steadily since the co-crystal structure was
provided of the DNA-binding domain of HNF-3γ complexed with its target DNA sequence (21).
From this structure, it was determined that members of the eukaryotic HNF-3/fork head family
of proteins mediate contacts with DNA through a novel α/β DNA-binding domain. The N-
terminal half of this domain formed a HTH-like structure, with the α-helices extended in length,
relative to those in the canonical HTH proteins, with the first and recognition helices being 10
6and 14 amino acids in length, respectively. In addition, the turn in the HTH region of HNF-3γ
was 8 residues, at least twice the length seen in canonical HTH domains, creating an angle
between the two helices of 140° (22). The DNA recognition helix was positioned in the major
groove of the DNA duplex, inducing a narrowing of this groove, and an overall bend of ∼13°
(21). The average helical twist of the DNA was increased slightly, to 35°. The HNF-3γ DNA-
binding fold revealed an unusual, three-stranded, antiparallel β-sheet from which two loops, or
“wings” extended. Interestingly, residues from each of these wings were shown to contact DNA,
prompting the designation of this DNA recognition motif as the “winged helix” motif.
Winged Helix DNA-Binding Motif
Numerous DNA-binding proteins with a winged helix DNA recognition motif have since
been characterized in eukarya, prokarya, archaea, and viruses. Particular interest, in regards to
elucidating archaeal transcriptional regulation, has stemmed from analyses of the known archaeal
genomes which suggest that most of the predicted HTH proteins, and most of the putative
transcriptional regulators, in these organisms belong to the winged helix subfamily of DNA-
binding proteins (2, 16, 23). However, this DNA-binding motif is not restricted to transcriptional
activators and repressors; histone H5 also binds DNA via a winged helix motif (22).
The winged helix DNA binding motif, also referred to as the winged helix-turn-helix
(wHTH) motif, is defined topologically by secondary structure elements arranged in the
following order: H1-S1-H2-H3-S2-W1-S3-W2, where “H” represents α-helix, “S” represents β-
strand, and “W” represents a loop (5). The sequence spanning α-helices H2 through H3
constitutes the general HTH motif, with H3 being the DNA recognition helix. The two
eponymous “wing” structures are actually formed by β-strands and loops; “wing 1” is a β-hairpin
motif, comprised of the S2-W1-S3 secondary structure elements and “wing 2” is formed by the
7S3-W2 elements. The three β-strands interact to form an antiparallel β-sheet, however, in some
winged helix proteins S1 is represented by a single, hydrophobic residue (21, 24-26). Whereas
wing 1 is invariably present in winged helix proteins, some members of this family do not
contain wing 2, as observed in the crystal structures of the winged helix DNA-binding domains
of E2F4, DP2, histone H5 and MarR (22, 26, 27). As observed in HNF-3λ, the length of the turn
in the winged helix motif can vary significantly from the 3-4 residues found in canonical HTH
proteins (21). Consequently, greater variation in the angle between the two helices of the HTH
motif is observed amongst the proteins in the winged helix family, than in the canonical HTH
proteins. For example, the turn in DP2 is approximately 10 residues in length, whereas the turn
in BirA is approximately 3 amino acids, allowing angles of 100° and 150°, respectively (5, 25,
27).
DNA Recognition by Winged Helix Proteins (Role of the Wings)
Structural analysis of winged helix proteins complexed with their target DNA sites
reveals that this family is similar to HTH proteins, in that proteins similar in the tertiary
structures of their DNA-binding motifs often differ in the manner in which they contact the DNA
(28). The DNA-recognition helix (H3) almost invariably contributes most of the contacts
determining sequence-specificity. However, the role of the wing(s) in contributing to DNA-
binding affinity and specificity seems to vary widely, with the wings of some proteins being
critical for site-specific DNA-binding by mediating numerous base-specific and sugar-phosphate
backbone contacts, while in other proteins, the wings mediate few contacts. Moreover, the
relative contributions from each wing (when both are present) also varies. The co-crystal
structure of HNF-3λ with its target DNA-site revealed that of the 17 amino acid-mediated DNA
contacts, 6 were contributed from the wing 2 structure, including three hydrogen bonds with
8backbone phosphates, one hydrophobic interaction with a backbone ribose, one direct hydrogen
bond with a base in the minor groove, and one water-mediated contact with a base in the major
groove. In contrast, wing 1 contributed one hydrogen bond to the phosphate backbone from each
of the S3 and W1 elements (21). Solution NMR analyses of the eukaryotic protein genesis
indicate that wing 1 makes contacts with the DNA minor groove but that this wing is
conformationally flexible, even in the DNA-bound state. Wing 2 appears to become less flexible
upon complex formation, suggesting its importance in stabilizing the interaction. Evidence
indicates that it is unlikely to contribute to sequence specificity (29-31). Conversely, wing 1
appears to be more important than wing 2 in stabilizing the BmrR-DNA complex; wing 1 from
BmrR mediates four hydrogen bond and hydrophobic contacts with the sugar-phosphate
backbone at its target DNA sequence, and forms a hydrogen bond and a hydrophobic interaction
with two bases in the minor groove (Fig. 1.2) (32). NMR structural analysis of the bacteriophage
protein MuR in complex with its cognate DNA site reveals that the β-hairpin wing 1 undergoes a
transition from a disordered state to a defined conformation upon DNA-binding, and that side
chains from the wing hydrogen bond with bases in the minor groove, thus immobilizing the wing
(33). Similarly, wing 1 of FadR mediates sequence-specific contact between a histidine with two
bases in the minor groove; substitution of this histidine with a glycine completely disrupts DNA
binding (34, 35). The wing-mediated DNA contacts in FadR allows an unusual mode of binding
in which only the N-terminal end of each recognition helix of the homodimer contacts the DNA,
allowing both recognition helices to occupy the same major groove (34). However, the wing
structures do not always appear to be important in stabilizing the protein-DNA complex. The co-
crystal structure of the E2F4-DP2 heterodimer with its cognate DNA-binding site revealed that
the single wing from E2F4 mediates two contacts with backbone phosphates and the single wing
9     
Fig. 1.2  DNA-binding by a winged helix motif. The DNA recognition helix (green) of BmrR
(from the MerR family of transcriptional regulators) is inserted into the DNA major groove
(blue). “N” identifies the amino-terminal end of the helix. The β-hairpin, wing 1, motif is
comprised of secondary structure elements topologically arranged (in the N- to C- terminal
direction): β-strand (red), loop (yellow), β-strand (orange). Only a single strand of the cognate
BmrR DNA-binding site is shown.
N
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from DP2 mediates only one hydrogen bond with a backbone phosphate. For this protein-DNA
complex it is apparent that the wings make only slight contributions to the complex stability (27).
The co-crystal structure of the winged helix protein RFX1 with its site-specific DNA-
binding site revealed a strikingly different mode of interacting with the DNA duplex (36). The β-
hairpin, wing 1, structure makes extensive base-specific hydrogen bonds with the DNA major
groove in one half-site of the recognition sequence, narrowing the major groove by 1 Å.
Surprisingly, the α-helix corresponding to the DNA recognition helix mediates only a single
hydrogen bond between a lysine and a cytosine in the minor groove on the opposite face of the
same half-site, causing the minor groove to widen by more than 3 Å.
Discovery of the mar Regulon and the Identification of MarR
The identification of the MarR (multiple antibiotic resistance regulator) family of
transcriptional regulators began with the identification of a chromosomally encoded mechanism
of multidrug resistance in E. coli K-12 (37, 38). Genetic selections identified mutants that
exhibited resistance to a broad range of antibiotics including tetracycline, chloramphenicol, β-
lactams, puromycin, nalidixic acid, penicillins, fluoroquinolones, and organic solvents (37-40).
The mar (multiple antibiotic resistance) phenotype was shown to be conferred by the marRAB
operon, specifically by the expression of marA, which encodes a transcriptional activator
belonging to the AraC family (20, 41-43). MarA is an activator of the marRAB operon and
induces the expression of a number of genes responsible for the mar phenotype, including the
expression of the AcrAB-TolC multidrug efflux system and the gene, micF, that downregulates
the synthesis of the porin OmpF (39, 44-47). In vivo upregulation of marRAB expression and the
mar phenotype was shown to be inducible by a range of antibiotics and anionic lipophilic
compounds, including 2, 4-dinitrophenol, menadione, plumbagin, and salicylic acid (48, 49).
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The product of the first gene of this locus, MarR (144 amino acids), was shown to be a
transcriptional repressor of the marRAB operon (48, 50). MarR binds to two separate 21 bp sites
in the marRAB promoter/operator region (marO) (51). An apparent Kd of ~1 nM was calculated
for MarR binding to marO. DNaseI footprinting indicated that MarR binding site I overlaps the
predicted –35 and –10 promoter elements and site II overlaps the putative ribosome binding site
and ends immediately before the first codon of marR (51). The size of each footprint, and the
fact that each binding site is palindromic, with 5 bp half-sites separated by 2 bp, is consistent
with MarR binding as a homodimer at each site and is supported by size-exclusion
chromatography evidence that uncomplexed MarR exists as a dimer, or higher order oligomers,
in solution (51). Interestingly, a number of phenolic compounds that have been shown to
increase marRAB expression in vivo also antagonize MarR-marO complex formation in vitro,
including 2, 4-dinitrophenol, menadione, plumbagin, and salicylic acid (52). MarR was measured
to bind salicylic acid with an apparent Kd of 0.5 mM by equilibrium dialysis (51). These results,
in toto, revealed a system of intrinsic multidrug resistance in E. coli that is under the control of a
novel transcriptional repressor, MarR, that responds to cytoplasmic phenolic compounds.
Functional marRAB  operons have since been identified in Salmonella typhimurium and
Enterobacter aerogenes (53, 54).
Structural Analysis of MarR Homologs
A search of the sequenced eukaryotic and prokaryotic genomes reveals numerous
predicted MarR homologs throughout the bacterial and archaeal domains. However, to date,
structural data has only been provided for two members of the MarR subfamily of winged helix
DNA-binding proteins.
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The co-crystal structure of a MarR-salicylate complex was determined at 2.3 Å resolution
and reveals the protein to exist as a dimer with a pyramidal shape and overall dimensions of 50 x
55 x 45 Å3 (Fig. 1.3) (26). Each monomer consists of 6 α-helices and two β-strands. The N-
terminal region encompassing α-helix 1, and the C-terminal region encompassing helices 5 and
6, interdigitate with the corresponding regions of the other subunit to form a dimerization
domain with a buried surface area of 3570 Å2. The stabilization of MarR as a homodimer is
predominantly mediated by hydrophobic contacts involving 10 residues from each subunit.
Several inter-subunit hydrogen bonds (H-bonds) in this domain contribute to dimer stability: the
Nζ of a lysine in helix 1 H-bonds with the main chain carbonyl of the C-terminal residue, and the
Nζ of a lysine in helix 6 H-bonds with the main chain carbonyl in the N-terminal coil region.
Helices 1 and 5 of each subunit connect the dimerization domain to a globular DNA-
binding domain, such that the two DNA-binding “lobes” of the dimer are juxtaposed and related
by a two-fold rotational symmetry. The topological arrangement of the secondary structure
elements in the DNA-binding domain (H1-S1-H2-H3-S2-W1-S3) indicates that MarR binds via
a winged helix motif. Each DNA-binding domain is stabilized by hydrophobic interactions
involving 14 residues from each of the secondary structural elements, which serve to make the
domain compact. The residues spanning MarR helices 3 and 4 (corresponding to H2-H3 above)
constitute the HTH motif. The β-hairpin (S2-W1-S3) following the HTH motif forms the
eponymous “wing” structure. The β-strands (S1, S2, S3) in each MarR subunit form an
antiparallel β-sheet, with S1 being comprised of a single isoleucine residue, similar to the
structures of OmpR and BirA (24, 25). The wing extending from S3 in some winged helix
proteins is absent from the DNA-binding domain of MarR, resembling the structures of E2F4,
DP2, and histone H5 (22, 27). The surface potential of each DNA-binding domain is highly
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Fig. 1.3.  MarR-salicylate co-crystal structure. MarR is shown as a monomer with the N- and
C- termini labeled. MarR α-helices are identified as α1-6 and β-strands as β1 and β2. The wing
is comprised of β1, β2, and the intervening loop (yellow). The DNA-recognition helix (green) is















electropositive, and a 6 Å wide cleft separates the lobes from each subunit. In this salicylate-
bound structure, the DNA-binding lobes of MarR interact through two salt bridges: D67 from the
turn of the HTH contacts R73´ in the putative recognition helix of the other subunit (and the
reciprocal interaction).
MexR is a MarR homolog from Pseudomonas aeruginosa that serves as a repressor of the
MexAB-OprM multidrug efflux operon (55). The crystal structure of the MexR dimer in the
absence of effector compounds was solved at a resolution of 2.1 Å and revealed an overall,
pyramidal structure very similar to MarR (Fig. 1.4) (56). Four copies of the MexR dimer were
present in the crystallographic asymmetric unit, providing several conformational views of the
dimer. The MexR monomer is 147 amino acids in length and is comprised of 6 α-helices and 3
β-strands. The N- and C-terminal regions encompassing α-helices 1, 5, and 6 from each subunit
intertwine with the reciprocal regions in the other subunit to create a dimerization interface with
a total buried surface area ranging from 4360 – 4930 Å3. Stabilization of the dimer is provided
almost entirely by hydrophobic contacts. Helices 1 and 5 of each subunit connect the
dimerization domain to a compact, globular DNA-binding domain (residues 36 – 97).  The
topological arrangement of the secondary structure elements of the DNA-binding domain
indicates a winged helix fold, with the sequence spanning helices 3 and 4 forming the HTH. β-
strands 2 and 3 and the intervening sequence form the wing. As for MarR, MexR lacks a wing 2
structure. The two salt bridges that connect the DNA-binding lobes of the MarR dimer are absent
in the MexR structure.
Structural Evidence for Mechanisms of DNA-Binding by MarR Homologs
The biochemical and genetic data, to date, is insufficient to explain the DNA-binding
mechanism of MarR.  A MarR-marO co-crystal structure, and biophysical analysis of MarR are
15
Fig. 1.4  Comparison of the predicted MexR “closed” and “open” conformations. The
individual subunits of the MexR dimer are colored red and blue (dimer AB) or yellow and green
(dimer CD). MexR dimer AB is in the “closed” conformation, predicted to resemble its ligand-
bound state. MexR dimer CD is in the “open” conformation, suggested to resemble its DNA-
binding conformation. Indicated below each structure is the distance separating the central
residues in the DNA recognition helices from each half of the dimer.
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critically needed to solve this mystery. The structure of salicylate-bound MarR does not allow
modeling onto B-DNA with the known MarR binding sequences. However, this finding is
consistent with evidence that salicylate is a negative effector of MarR-marO complex formation.
Nevertheless, the combined data from the MarR-salicylate co-crystal structure, MarR
footprinting experiments, and MarR mutational studies, are suggestive of possible modes of
DNA-recognition. The identification of 5 bp inverted repeats separated by 2 bp, within each 21
bp MarR binding site, would place the half-site sequences on opposite faces of the DNA double
helix (51). As prokaryotic transcriptional regulators almost invariably bind DNA as homodimers
to palindromic sequences, it is reasonable to suspect that MarR does so as well. Mutational
studies of MarR have shown that both the wing and the DNA recognition helix are critical for
MarR-DNA complex formation, so it is highly probable that the winged helix motif of each
MarR subunit binds at each half-site (11). The DNA-binding lobes of the salicylate-bound MarR
structure would have to undergo significant conformational changes to accommodate binding to
DNA half-sites on opposite faces of the double helix. Such conformational shifts of the globular
DNA-binding domains would require flexibility in the α-helices that connect the lobes to the
dimerization domain. That MarR possesses such intrinsic flexibility is supported by the crystal
structure, which indicates poorly ordered loop regions that might allow conformational shifts in
the α-helices that form the dimerization domain (26). Also, the van der Waals interactions that
stabilize the dimer do not require specific geometries of the residues involved, suggesting that
flexibility would be allowed at the dimer interface. In addition, in vivo selections of MarR
mutants with enhanced DNA-binding activity indicated that residues in the N- and C-terminal
regions of MarR (in addition to the wing) are important in defining DNA-binding affinity (57).
In vivo selection of mutants with reduced DNA-binding activities primarily identified residues in
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the recognition helix and wing, but also indicated that mutations to residues in the C-terminal
region reduced DNA-binding (11). Furthermore, MarR crystals grown in the absence of ligand
were determined to be highly disordered, consistent with MarR being intrinsically flexible (26).
Protein-induced conformational changes in the DNA-binding site could also accommodate
binding of a MarR dimer. For example, overwinding or underwinding of the DNA duplex, to
increase or decrease the helical twist, respectively, would serve to position the major groove of
each half-site in an orientation that would require a less drastic conformational change in the
MarR dimer. Biophysical experiments to ascertain the conformational flexibility of MarR and its
cognate DNA-binding sequence would be crucial in testing these possibilities.
The crystal structure of MexR in the absence of a ligand revealed a dimer in a
conformation that could be docked to a linear, B-form representation of its known DNA-binding
sequence with a reasonably good fit (56). The sequence-specific MexR binding site contains 5 bp
half-sites separated by 5 bp, so that the center of each half-site would likely be positioned on the
same face of the DNA duplex (58). The MexR dimer (denoted “CD”) modeled onto the DNA-
binding site was determined to be in an “open” conformation, such that the globular DNA-
binding lobes were separated by a distance optimal for the insertion of the recognition helices
into consecutive major grooves, and the wings were positioned to mediate contacts with the
sugar-phosphate backbone and minor groove (56). The MexR dimer CD structure reveals the
centers of the two recognition helices to be separated by 29.2 Å, close to the 34 Å distance that
separates the center of each half-site in linear B-form DNA. This “open” conformation is likely
maintained by electrostatic repulsions between positively charged residues lining the crevice
between the DNA-binding domains. The model suggests that bending of the DNA duplex, or an
increase in the helical twist, might occur upon MexR binding to accommodate a tighter fit.
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Additionally, the DNA-binding lobes of the MexR dimer might undergo conformational shifts, a
possibility suggested by the intrinsic flexibility of the MexR dimer (see below).
Structural Data on Phenolic Recognition in the MarR Subfamily
The MarR-salicylate co-crystal structure revealed two ligand binding sites per subunit,
labeled SAL-A and SAL-B (Fig. 1.5) (26). Interestingly, the bound salicylates flanked the
proposed DNA-recognition helix on either side. Ligand binding site SAL-A is packed in the
interior of the globular DNA-binding domain, and is formed by residues from both helices of the
HTH motif and from the wing. The side chain hydroxyl of T72 from the recognition helix forms
an H-bond with the salicylate hydroxyl group, the guanidinium group of R86 H-bonds with the
salicylate carboxylate, and the aliphatic pyrrolidone ring of P57 is positioned within 3.5 Å over
the hydrophobic ring of salicylate. Site SAL-B is exposed to the surrounding solvent and most
contacts with salicylate are mediated by residues from the recognition helix. The backbone
carbonyl of A70 H-bonds to the salicylate hydroxyl, the guanidinium group of R77 H-bonds with
the salicylate carboxylate, and the hydrophobic ring of salicylate is within 3.5 Å of the
hydrophobic side chain of M74. Q42 from helix 2 may also H-bond with the salicylate
carboxylate.
The H-bond forming residues in site SAL-A are strictly conserved in MexR, and the
MarR proline mediating hydrophobic contact with the salicylate ring is replaced with a leucine in
MexR. Site SAL-B, however, is not conserved in MexR. The natural ligands of MexR are
unknown and the structure was determined in the absence of any potential effectors (56).
However, the C-terminal polypeptide from an adjacent dimer was inserted in the cleft between
the DNA-binding domains of MexR dimer “AB”, resulting in a dimer significantly different in
conformation than the dimer CD that was modeled onto the MexR DNA-binding site (see
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Fig. 1.5  MarR salicylate binding sites SAL-A and SAL-B. Salicylates are colored red.
Oxygen, nitrogen, and sulfur atoms from MarR side-chains are colored red, blue, and yellow,








below). The polypeptide was stabilized between the DNA-binding lobes by electrostatic
interactions between the positively charged residues of the dimer lining the crevice and
negatively charged glutamate and aspartate residues from the inserted polypeptide. Several van
der Waals contacts between proline, leucine, and isoleucine residues in the polypeptide with
hydrophobic residues lining the crevice of the dimer also stabilized the interaction.
Proposed Mechanisms of Allosteric Regulation of MarR Proteins
As discussed above, the salicylate-bound structure of MarR is in a conformation that is
unlikely to bind its sequence specific DNA-binding site (26). Such binding would require
significant conformational flexibility in the protein and/or the DNA duplex. The location of the
two salicylate binding sites on either side of the proposed DNA recognition helix is suggestive of
possible mechanisms by which phenolic ligands antagonize MarR-DNA interaction. As both
ligand-binding sites SAL-A and SAL-B are composed of residues from the DNA-recognition
helix and wing motif, and as both of these regions of the winged helix fold have been shown to
be critical for DNA-binding, it is clear that the ligand- and DNA-binding sites are not separate in
MarR. It is plausible that ligand binding at one, or both, sites coordinates residues required for
direct, or water-mediated, contacts with the cognate DNA-binding site, thus preventing
sequence-specific MarR-marO complex formation (11). Alternatively, or in combination with
the effect posited above, ligand binding might stabilize a MarR dimer conformation that cannot
accommodate the insertion of the recognition helices into the major grooves at the binding
sequence half-sites. The suggested intrinsic flexibility of MarR at the dimerization interface is
consistent with a ligand-mediated conformational shift in the relative positions of the DNA-
binding lobes, from a DNA-binding state, to the state observed in the crystal structure.
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The four dimers present in the crystallographic asymmetric unit of MexR provided a
fortuitous glimpse of a possible mechanism of ligand-mediated allosteric control of MexR-DNA
binding (56). A comparison of the “open” MexR dimer CD conformation, that was readily
modeled onto its linear B-form DNA binding site, with the MexR dimer AB-polypeptide
conformation, revealed the latter to be incompatible with binding to its recognition sequence.
Notably, the distance separating the centers of the recognition helices had been reduced to 22.6
Å in the MexR dimer AB, compared to the distance of 29.2 Å observed in the “open”
conformation (Fig. 1.4). Comparisons of all four dimer representations revealed that the basis for
this conformational shift resided in the intrinsic flexibility of the dimerization domain. Whereas
the winged helix DNA-binding domains appeared to shift in orientation as a rigid body, flexible
loop regions allow for significant conformational flexibility in α-helices 1, 5, and 6. The helix
orientations of α-helices 1, 5, and 6 vary by 17°, 6.8°, and 12.1°, respectively, with their
midpoint positions deviating by 4.9 Å, 1.7 Å, and 8.2 Å. This flexibility of the helices that
comprise the dimerization domain is consistent with variable geometries being allowed for the
van der Waals contacts that stabilize the dimer. As α-helices 1 and 5 connect the dimerization
domain to the DNA-binding domain, their flexibility results in concomitant shifts in the DNA-
binding lobes. The “closed” conformation observed for MexR dimer AB suggests that ligands
may disrupt MexR-DNA complex formation by neutralizing the electrostatic repulsions that
otherwise maintain the dimer in an “open”, DNA-binding conformation. Additional hydrophobic
contacts between the ligand and residues lining the crevice of the MexR dimer contribute to
bring the DNA-binding lobes into closer proximity. As all known ligands of MarR homologs are
anionic lipophilic compounds, it is tempting to speculate that members of this family share a
similar mechanism of allosteric control.
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Other Members of the MarR Family
Since the discovery of MarR, a number of MarR homologs have been predicted from the
genomes of Gram-positive and Gram-negative bacteria, mycobacteria, and archaea. However,
only a small subset of the potential MarR homologs have been characterized biochemically or
genetically.
All members of the MarR family possess a winged helix DNA-binding motif. All
characterized homologs exist as dimers in both the uncomplexed and DNA-bound states and this
may be a defining characteristic of this family (lower proportions of higher order oligomers have
been observed for some uncomplexed homologs). Consistent with the observed DNA-binding
stoichiometries, MarR homologs invariably bind to palindromic or pseudopalindromic DNA
sequences that presumably reflect the two-fold rotational symmetry of the protein dimer. The
gene encoding each MarR homolog is generally part of a gene cluster containing the gene(s)
under its regulation (with the possible exceptions of FarR and PecS). In some cases, the MarR
homolog is encoded in its regulated operon. A large proportion of the characterized family
members are adjacent to the divergently transcribed gene(s) they regulate, such that the MarR
homolog binding site(s) reside in the intergenic region containing the associated, divergent
promoters.  More than half of the characterized MarR homologs have been shown to be
autoregulatory. Most members of this family serve as repressors of gene transcription, but
several activators have been identified. Response to environmental phenolic ligands has been
demonstrated for a number of MarR proteins. Specifically, ligand-responsive MarR proteins
almost invariably respond to anionic lipophilic compounds in their capacity to bind their cognate
DNA sequences.  The physiological roles of MarR proteins can be classified into three general
categories, with some proteins serving multiple regulatory roles: 1) regulation of response to
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environmental stress, 2) regulation of aromatic catabolic pathways, and 3) regulation of virulence
factors.
MarR Regulators of Stress Response
The MarR homolog, EmrR from E. coli, was first demonstrated to be repressor of
microcin B and C production and later shown to be the encoded by the first gene of the emrRAB
operon, which encodes a multidrug resistance pump (59, 60). Analyses in vivo using lacZ fusions
demonstrated that emrR expression represses the emrRAB locus and that this repression could be
relieved by certain antibiotics and protonophores that are the targets of the EmrAB pump (60). In
addition, the MarR ligands, salicylate and 2,4-dinitrophenol, also induced expression of this
operon. Gel electrophoresis under non-reducing conditions suggested that EmrR exists as a
dimer in solution (61). DNaseI footprinting analysis revealed a surprisingly large EmrR binding
site of 42 bp that partially overlaps the –35 promoter element and extends past the start site of
transcription for the emrRAB operon (62). This site contains a pseudopalindromic sequence
comprised of 9 bp half-sites separated by 3 bp. Several compounds were shown to negatively
effect EmrR-DNA complex formation. Direct binding between potential ligands and EmrR was
demonstrated using equilibrium dialysis and the ligand binding affinities of 2,4-dinitrophenol
and two protonophores were measured spectrophotometrically, revealing apparent dissociation
constants of approximately 2.0, 3.0, and 15.0 µM, respectively (61). Interestingly, fitting the data
to the Scatchard equation suggested that each ligand  bound to a single site in the EmrR
monomer.
The gene encoding the MarR homolog, MexR from P. aeruginosa, is adjacent to the
oppositely oriented mexAB-oprM operon that encodes a non-ATPase, multisubstrate efflux pump
that contributes to this organism’s intrinsic multidrug resistance (55). Initial genetic evidence
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suggested a regulatory role for MexR. A mexR mutant strain was shown to have enhanced
resistance to antibiotics, and MexR was shown to reduce the expression of mexA:lacZ,
mexA:phoA, and mexR:lacZ fusions, suggesting that MexR is an autorepressor and repressor of
the mexAB-oprM operon (55). Despite suggestions that MexR might possess dual repressor and
activator roles in vivo, extensive genetic experiments indicate that MexR functions only as a
repressor of this operon (63). DNaseI footprinting identified two MexR binding sites within the
274 bp intergenic region that separates mexR and mexA (58). Site I is ∼29 bp and overlaps the
predicted –10 promoter element for mexR and a putative –35 promoter element for the mexAB-
oprM operon. Site II is ∼28 bp and overlaps the predicted –35 promoter element for mexR and a
putative –10 promoter element for the operon. Each site contains a palindromic sequence
comprised of 5 bp half-sites separated by 5 bp. Curiously, the footprints of sites I and II are
separated by only 3 bp (58). In addition to the crystal structure evidence, two-hybrid experiments
are consistent with MexR existing as a dimer in solution, and it is therefore likely that MexR
binds each of its palindromic sites as a dimer (64). It will be interesting to see if cooperativity
exists in MexR binding to its closely spaced binding sequences. Surprisingly, the selection of
trans-dominant MexR mutants that were defective in DNA-binding, but not dimerization,
predominantly identified single-amino acid substitutions of hydrophobic residues in the DNA-
binding domain. Only 2 of the 25 mutations were to charged residues, suggesting the importance
of hydrophobic contacts in this region in stabilizing the winged helix motif in a conformation
that can accommodate DNA-binding (65).
A member of the MarR family has been characterized from Neisseria gonorrhoeae that
likely mediates the resistance of this organism to antimicrobial hydrophobic agents. The farAB
operon of N. gonorrhoeae encodes an efflux pump that exports out of the cell host-derived
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antimicrobial agents such as long-chain fatty acids (FAs). Using lacZ reporter fusions, it was
shown that farAB and farR expression was enhanced in strains mutated at farR (66). Also, strains
mutated at the farR site were less resistant to FAs. Electrophoretic mobility shift assays
demonstrated that FarR binds sequence specifically in the farAB and farR promoter regions.
Thus, FarR is autoregulatory and represses the farAB efflux system, but it remains to be
determined if its regulatory activity is affected by certain fatty acids or other potential ligands.
MarR Regulators of Aromatic Catabolism
A phenolic sensing protein from Rhodopseudomonas palustris has been characterized as
an inducer of the badDEFG operon, which encodes benzoyl-CoA reductase, an enzyme involved
in the anaerobic catabolism of benzoate (67). Analysis in vivo using a badE:`lacZ fusion
construct demonstrated that, in the presence of benzoate or 4-hydroxybenzoate, BadR increases
lacZ expression approximately 5-fold. Strains deficient in badR grew slowly under anaerobic
conditions with benzoate as a carbon source. Though not shown, it is likely that the stimulatory
effect of BadR occurs through direct binding of benzoyl-CoA reductase substrates to this protein,
which induces DNA-binding of BadR to the promoter of badDEFG. This proposed mechanism is
interesting in light of the fact that the known ligands of other MarR homologs almost invariably
antagonize DNA-binding. The badR gene is part of a gene cluster including the badDEFG
operon, but is transcribed from a separate promoter. The mechanism by which the proposed
DNA-binding by BadR activates gene expression, and whether or not BadR is autoregulatory,
remains to be determined.
The MarR homolog, CbaR from Comamonas testosteroni BR60, is a phenolic-sensing
modulator of the cbaABC operon that encodes enzymes involved in the oxidation of 3-
chlorobenzoate (68). An intergenic region of 667 bp separates cbaR from the oppositely oriented
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cbaABC operon. Electrophoretic mobility shift assays, and in vivo analysis monitoring lacZ
expression, indicated that CbaR does not regulate its own expression. However, gel shifts and
DNaseI footprinting indicated that CbaR forms two distinct complexes, dissimilar in binding
affinities, in the promoter region of the cbaABC operon, suggesting that CbaR represses gene
expression. The high-affinity ∼22 bp binding site is located ∼40 bp downstream of the
transcriptional start site and contains a palindromic sequence comprised of 4 bp half-sites
separated by 6 or 9 base pairs. The low-affinity binding site contains a pseudopalindromic
sequence similar to the high-affinity sequence. The substrate of the enzymes encoded by the
cbaABC operon, 3-chlorobenzoate, is an efficient antagonist of CbaR complex formation at both
sites. Interestingly, the downstream product of 3-chlorobenzoate catabolism, protocatechuate, is
also an efficient antagonist, suggesting a mechanism of positive feedback in cbaABC expression.
Curiously, the phenolic compounds 3-hydroxybenzoate and 3-carboxybenzoate might promote a
slight increase in the affinity of CbaR for each of its binding sites, suggesting that these
compounds enhance CbaR-mediated gene repression.
A MarR homolog has been characterized from the ruminal bacterium Butyrivibrio
fibrisolvens E14 that regulates the expression of an enzyme involved in the catabolism of
polysaccharide derivatives in plant cell walls (69). It was shown that cells overexpressing a 142
residue, 16 kDa protein, CinR, and a cinnamoyl ester hydrolase (CinB)  displayed less activity
from this enzyme than did cells overexpressing CinB alone. The open reading frames of cinR and
cinB are oriented in the opposite direction in the Butyrivibrio genome and are separated by an
intergenic region of 170 bp containing predicted, overlapping promoter elements for each gene.
Gel shifts demonstrated that CinR binds a DNA fragment containing the intergenic region
between cinR and cinB. Sequence analysis identified two identical 16 bp palindromic sites in this
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intergenic region, comprised of 8 bp half-sites. One of these potential CinR binding sites
overlaps the predicted cinR transcriptional start site and the other lies just downstream of the
putative cinB transcriptional start site, suggesting that CinR represses its own expression and that
of cinB. Two cinnamic acid sugar esters, potential substrates of CinB, were shown to antagonize
CinR-DNA complex formation. Notably, certain cinnamic acids, sugars, and a non-sugar
cinnamic acid ester were not negative effectors of CinR DNA-binding activity, indicating that
both the sugar and cinnamic groups are essential components of a CinR effector.
The MarR homolog HcaR, from Acinetobacter sp. strain ADP1, regulates the hcaABCDE
operon that encodes genes required for the catabolism of plant-derived hydroxycinnamates.
Genetic analyses indicated that HcaR represses this operon and that this repression is relieved by
hydoxycinnamoyl-CoA thioesters (70). The gene encoding HcaR and the hcaABCDE operon are
part of the same gene cluster, but are divergently transcribed. Direct interaction of HcaR with the
operon promoter has not been demonstrated and the HcaR recognition sequence remains
unknown.
The hpa-meta operon of E. coli encodes a set of genes required for the catabolism of 4-
hydroxyphenylacetic acid (4-HPA). An intergenic region of 219 bp separates the first ORF of
this operon from a divergently transcribed gene encoding HpaR. In vitro transcription assays
demonstrated that HpaR repressed the expression from the hpa-meta operon promoter and that 4-
HPA effectively relieved this repression (71). In addition, 4-HPA, and two structurally similar
compounds (3-HPA and 3,4-HPA), increased expression from a lacZ fusion with the hpa-meta
operon promoter. In vivo assays involving a lacZ translational fusion with the hpaR promoter
demonstrated that HpaR is an autorepressor, and the same phenolic compounds listed above
relieve that repression. EMSAs and DNaseI footprinting identified two 27 bp HpaR binding sites
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in the intergenic region between hpaR and the hpa-meta operon. The affinity of HpaR for one
site (OPR1) was 10-fold higher than for the other site (OPR2). Site OPR1 overlapped the –10
promoter element and transcriptional start site of the hpa-meta operon and contained a
palindromic sequence comprised of 9 bp half-sites separated by 4 bp. Site OPR2 was located
between the transcriptional start site and ribosome binding site of hpaR. OPR2 contained a
pseudopalindromic sequence, with one of its half-sites differing in 5 bp from the half-sites in
OPR1. Interestingly, gel shifts comparing HpaR binding affinities to DNA fragments containing
one, or both, sites indicated that HpaR binding is positively cooperative at these sites. Potassium
permanganate footprinting demonstrated that HpaR likely represses transcription of the hpa-meta
operon by blocking promoter escape by RNA polymerase. In the presence of HpaR, the open
complex was shifted upstream of the HpaR binding site, and partially overlapped the –35
promoter element (71).
MarR Regulators of Virulence Factors
A MarR homolog from the nitrogen-fixing bacterium, Sinorhizobium meliloti, has been
shown to activate transcription of three exp operons that are involved in the production of
galactoglucan, an exopolysaccharide required for this organism to infect plant roots for nodule
formation (72, 73). ExpG was shown to mediate this activation by binding to promoter regions in
the exp gene cluster (74). Size exclusion chromatography suggested that this protein, ExpG,
exists as a dimer in solution (75). Analysis of ExpG-DNA binding using atomic force
microscopy (AFM) revealed that the DNA curvature at the ExpG binding site changes upon
complex dissociation, suggesting that ExpG induces DNA bending upon complex association.
Electrophoretic mobility shift assays and AFM experiments demonstrated that ExpG binding
sites require a palindromic sequence comprised of 6 bp half-sites separated by 3 bp.
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Measurements of the binding kinetics for ExpG at 3 different promoter binding sites indicated
that the ExpG dimer binds with a very high on-rate (ranging from 1.0 – 5.0 x 105 M-1s-1) and
dissociates with a very low off-rate (ranging from 4.3 – 1.3 x 10-4 s-1) indicating dissociation
constants ranging from 0.58 – 1.3 nM. Interestingly, the DNA-binding affinity of ExpG is
enhanced by the presence of short conserved sequences (“boxes 1 and 2”) located on either side
of the palindrome. The distance of these boxes from the conserved 21 bp sequence containing the
palindrome ranges from 5 – 30 bp. Dynamic force spectroscopy was used to calculate the natural
thermal off-rates for the binding kinetics between ExpG and a wild-type binding site, a binding-
site mutated in box 1, and a binding site mutated in box 2. The off-rate was increased
approximately 10-fold by a mutation in box 1 and approximately 100-fold by a mutation in box
2. Sites analogous to boxes 1 and 2 have not been described for any other MarR family member.
Gel shift experiments determined that the MarR homolog, PecS from Erwinia
chrysanthemi, binds specifically to the regulatory regions of pectinase and cellulase enzymes,
virulence factors required for this organism to infect plant cells (76, 77). PecS binds with  a Kd of
∼200 nM to the promoter regions of two pectinase genes and has been shown to be involved in a
complex regulatory system of these enzymes, involving CRP and another repressor, KdgR (77).
DNaseI footprinting experiments determined that PecS protects an ∼50 bp site in the pectinase
promoter region, which contains a high-affinity binding site for the activator, CRP, suggesting a
mechanism for PecS-induced transcriptional attenuation (77). A 23 bp consensus DNA-binding
sequence for PecS was defined and shown to contain a palindromic sequence comprised of 5 bp
half-sites separated by 3 bp (78). In addition, PecS has been shown to regulate the expression of
genes involved in the production of flagella, by binding to a regulatory region with an apparent
Kd of 20 nM (78). Furthermore, genetic experiments identified PecS as a repressor of a cluster of
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genes involved in the synthesis of the blue pigment, indigoidine (79). Gel shifts determined that
PecS binds to the promoter regions of two genes in this cluster, with apparent Kd’s of 5 and 20
nM. Interestingly, increased production of indigoidine, conferred by a pecS mutation in E.
chrysanthemi, resulted in a significant increase in tolerance to oxidative stress, presumably due
to the ability of this aromatic compound to scavenge reactive oxygen species (79).
Deinococcus radiodurans
Deinococcus radiodurans is one of 11 members belonging to the family Deinococcaceae,
which includes at least 7 members that are intrinsically resistant to extreme levels of radiation
and other sources of DNA damage, such as oxidative stress and dessication (80-84). Though
Deinococcus often stains Gram-positive, sequence comparisons of 16S rDNA suggests that this
lineage is most closely related to the thermophilic, Gram-negative genus, Thermus (85). This
relationship is consistent with the peptidoglycan chemotype shared by these two genera (86, 87).
The D. radiodurans genome is comprised of two chromosomes, one megaplasmid, and one
plasmid and is predicted to encode 3195 ORFs (88). D. radiodurans maintains 8-10 copies of its
genome during exponential growth and approximately 4 copies during stationary phase (89).
Interest in D. radiodurans has focused primarily on its ability to repair extensive levels of
DNA damage. It has been shown that D. radiodurans is approximately 50-fold more resistant to
ionizing radiation than is E. coli, demonstrating 10% survival at 800 kilorads, whereas E. coli
has 10% survival at 15 kilorads (90-92). This organism can survive high doses of acute gamma
radiation (greater than 1500 kilorads) and grow under conditions of prolonged exposure at 6
kilorads, remarkably without accumulating abnormal levels of mutations (93-95). Similar levels
of resistance are observed when D. radiodurans is exposed to prolonged dessication, UV
radiation, or oxidative stress (83, 92, 96). The damage accrued by the D. radiodurans genome
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under these conditions suggests that this organism’s intrinsic resistance is a consequence of a
remarkable DNA repair system (93, 97). Whereas E. coli can only sustain 10-15 double strand
breaks in its genome, D. radiodurans can repair up to 2000 such breaks (92). Efficient
homologous recombination is most likely the primary means by which D. radiodurans can
withstand such high levels of DNA damage (98, 99). However, numerous non-resistant
organisms possess the same complement of genes for recombination, leaving unresolved the full
mechanism by which D. radioduran’s maintains resistance to extreme levels of DNA damage
(92). Recent evidence demonstrates that the D. radiodurans nucleoid adopts an unusual toroidal
morphology, which suggests that efficient DNA recombination may be facilitated by the
alignment of homologous segments from multiple copies of the genome (100).
It has been noted that D. radiodurans undergoes a dose-dependent growth lag after
exposure to DNA-damaging events (92). Damaged nucleotides and nucleosides are exported
from the cell during this period of growth inhibition (101). In addition, D. radiodurans must
handle the enhanced levels of reactive oxygen species that are the direct products of ionizing and
UV radiation, dessication, and oxidative stress agents. Catalase and superoxide dismutase
enzymes have been shown to be critical in this regard, as mutations to these genes reduce D.
radiodurans resistance to ionizing radiation (96). In addition, the D. radiodurans genome
encodes two Dps (DNA protection during starvation) homologs. Dps proteins are structurally
related to ferritin, and have been shown to protect DNA from damage by physically binding
DNA and by chelating iron (102, 103). Iron, in its ferrous (Fe2+) state, can be particularly toxic to
aerobically respiring organisms such as D. radiodurans by reacting with hydrogen peroxide to
generate reactive oxygen species that are damaging to amino acids and lipids, as well as DNA
nucleobases. One of these Dps homologs in D. radiodurans, Dps-1, has been recently
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characterized and shown to possess ferroxidase activity, oxidizing Fe2+ to Fe3+ (104). The
dodecameric form of this protein stores the oxidized iron, while a dimeric form of Dps-1 protects
DNA from DNaseI and hydroxyl radical cleavage, suggesting a role for this protein in mediating
oxidative stress resistance in D. radiodurans (104).
As numerous MarR proteins have been shown to regulate prokaryotic stress responses to
toxic compounds and oxidative stress agents, the identification of two predicted MarR homologs
within the D. radiodurans genome suggested the possibility of other uncharacterized stress
response proteins that contribute to the extreme-resistance phenotype of this organism.
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CHAPTER 2
HUCR, A NOVEL URIC ACID RESPONSIVE MEMBER OF THE MARR
FAMILY OF TRANSCRIPTIONAL REGULATORS FROM
DEINOCOCCUS RADIODURANS
Introduction
Members of the MarR family of winged helix transcriptional regulators control a variety
of biological functions in bacteria and archaea (1).  Several transcriptional activators have been
identified in this family, but the majority of MarR homologs are transcriptional repressors (2, 3).
A number of bacterial MarR proteins regulate environmental stress responses and the expression
of pathogenic factors.  For example, MexR represses the MexAB-OprM operon of Pseudomonas
aeruginosa, an operon that encodes a tripartite efflux system responsible for this organism’s
intrinsic resistance to multiple antibiotics (4, 5).  PecS from Erwinia chrysanthemi regulates
pectinase and cellulase production, the main virulence determinants of this plant pathogen, and
the synthesis of indigoidine, an apparent scavenger of reactive oxygen species (6, 7).  Other
members of the MarR family regulate the catabolism of aromatic compounds, such as HpaR,
which mediates the catabolism of 4-hydroxyphenylacetic acid in Escherichia coli, and HpcR,
which regulates homoprotocatechuate catabolism (8, 9).  Autoregulation is a characteristic of a
number of MarR proteins, including the operon repressors EmrR and MarR, and several
homologs that are not encoded in the context of a contiguous operon, such as MexR and HpaR
(8, 10-12).
Phenolic ligands have been shown to regulate gene expression by negatively affecting
interactions of MarR homologs with their cognate promoter/operator regions.  Repressor activity
______________________________________________________________________________
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of EmrR on the multidrug resistance operon, emrRAB in E. coli, is antagonized in vitro by
sodium salicylate and a variety of structurally unrelated phenolic drugs that are putative ligands
of the multidrug pump encoded by this operon (10, 13).  The affinity of CinR, a repressor of a
cinnamoyl ester hydrolase from Butyrivibrio fibrisolvens E14, for its binding region is reduced in
vitro by cinnamic acid derivatives (14).  HpcR repression of homoprotocatechuate metabolic
genes, and HpaR repression of the hpa-meta operon, are relieved by the respective aromatic
substrates of these catabolic pathways (8, 9).  Similarly, the regulators of benzoic acid and 3-
chlorobenzoate catabolism, BadR and CbaR, respectively, respond to the aromatic substrates of
their pathways (2, 15).
The prototypical member of this protein family, MarR from E. coli, negatively regulates
the marRAB operon, the expression of which confers an intrinsic phenotypic resistance to
structurally diverse antibiotics, organic solvents, oxidative stress agents, and household
disinfectants (11, 16, 17).  MarR binds as a homodimer to two sites on the operator/promoter
(marO) of this operon with an apparent Kd of ~ 1nM, with site I partially overlapping the -35 and
-10 regions of the promoter and site II overlapping the putative ribosome binding site (18).  A
range of phenolic compounds induce marRAB transcription in vivo, including sodium salicylate,
cinnamate, 2,4-dinitrophenol, acetaminophen, sodium benzoate, tetracycline, and
chloramphenicol and a subset of these, as well as plumbagin and menadione, antagonize DNA
binding activity of MarR in vitro (16, 19-21).  Sodium salicylate has been shown to bind MarR
with an apparent Kd of 0.5 – 1 mM (18).  The 2.3 Å crystal structure of MarR bound to sodium
salicylate revealed two binding sites per monomer for this inducer, with each site flanking the
putative recognition helix of the DNA binding motif (22).
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The heterotrophic, mesophilic bacterium Deinococcus radiodurans is best known for its
resistance to high levels of ionizing and UV radiation, bulky chemical-adducts, and other agents
that damage DNA (23-25).  Genomic analysis revealed that D. radiodurans also encodes
orthologs of nearly every known bacterial stress response protein, suggesting mechanisms of
resistance to osmotic, temperature, pH, starvation, toxin, phage, dessication, antibiotic, and
oxidative stresses  (25, 26).  The presence of two genes encoding MarR homologs, dr1159 and
dra0248 (TIGR gene annotation), within the genome suggested an uncharacterized stress
response regulatory system or a novel mode of metabolic regulation in D. radiodurans.
In this paper, we report the cloning of dr1159 from D. radiodurans and the subsequent
purification of a hypothetical uricase regulator (HucR) belonging to the MarR family of
transcriptional regulators.  Characterization of this novel protein reveals that it binds as a dimer
with very high affinity to a promoter region shared between hucR and a neighboring uricase.
Through electrophoretic mobility shift assays (EMSAs) we demonstrate that this affinity is
antagonized by specific phenolic compounds, notably uric acid.  These results, in conjunction
with in vivo analyses, indicate a novel catabolic regulatory system in D. radiodurans.
Experimental Procedures
Cloning, Overexpression, and Purification of HucR
D. radiodurans R1 was kindly provided by J. Battista and genomic DNA was isolated as
described (27).  PCR amplification of the hucR ORF (dr1159) from the genome was achieved
using primers HucR-fwd (5'-GCT CGT GTT CAT ATG TCA GCC CGC-3'), which introduced
an NdeI site (bold) overlapping the first codon (underlined), and HucR-rev (5'-CCT TTC CGG
AAT TCC GGG AAT C-3'), which introduced an EcoRI site (bold) downstream of the hucR
stop codon.  The resulting 589 bp PCR product was cloned into pET-5a, generating pHucR.
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Plasmid pHucR was transformed into E. coli TOP10 (Invitrogen).  Fidelity of the construct was
verified by DNA sequencing.  Plasmid pSPW1 was subsequently transformed into E. coli
BL21(DE3)pLysS.  Cultures were grown in LB containing 100 µg/ml ampicillin at 37°C to A600
= 0.5 and HucR overexpression was induced with 0.2 mM isopropyl-1-thio-β - D -
galactopyranoside for 1 hour.  Cells were pelleted at 4°C and stored at -80°C.  All subsequent
steps were carried out at 0 - 4°C.  Cells were resuspended in lysis buffer (50 mM Tris-HCl (pH
8), 25 mM NaCl, 5% glycerol (v/v), 5 mM Na2EDTA, 0.15 mM phenyl methyl sulfonyl fluoride
(PMSF), 10 mM 2-mercaptoethanol) and incubated with 200 µg/ml lysozyme for 1 hour.  Triton
X-100 and NaCl were added to final concentrations of 0.05% (v/v) and 0.5 M, respectively.
DNA was removed from the lysate by slow addition of Polymin P to a final concentration of
0.5% (v/v) followed by centrifugation at 11,000g for 20 minutes.  The supernatant was dialyzed
overnight against 30 volumes of HA buffer (20 mM Tris-HCl (pH 8.7), 50 mM KCl, 4.8%
glycerol (v/v), 1 mM Na2EDTA, 4.3 mM 2-mercaptoethanol, 0.2 mM PMSF) and centrifuged at
11,000g for 20 minutes.  The supernatant was loaded onto CM-Sepharose and DEAE-Sepharose
columns, linked in tandem and equilibrated with HA buffer, pH 8.7.  The HucR-containing flow
through and wash fractions were combined and concentrated using a Centriprep centrifugal filter
device (Millipore).  The concentrated retentate was dialyzed for 3 hours against 60 volumes of
HAP buffer (20 mM potassium phosphate (pH 7), 50 mM KCl, 4.8% glycerol (v/v), 1 mM
Na2EDTA, 4.3 mM 2-mercaptoethanol, 0.2 mM PMSF) and loaded onto a hydroxyapatite
column equilibrated with HAP buffer, pH 7.  The wash fractions containing HucR were loaded
onto a heparin column equilibrated with HAP buffer, pH 7, and HucR was eluted with a linear
gradient of 50 mM – 1 M KCl in HAP buffer, pH 7.  Peak fractions were pooled, concentrated,
and the glycerol concentration was increased to 20%.  The purity of HucR was established by
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SDS-PAGE and Coomassie staining. HucR concentration was ascertained
spectrophotometrically using ε280 = 13,512 M
-1cm-1 (calculated from amino acid extinction
coefficients), and verified by SDS-PAGE using bovine serum albumin (BSA) as a standard.
Circular Dichroism Spectroscopy
Circular dichroism (CD) spectroscopy was performed on an Aviv 202 CD
spectrophotometer.  HucR was diluted to 0.2 mg/ml in CD buffer A (20 mM potassium
phosphate (pH 7), 34 µM EDTA, 0.8% glycerol, 13 mM KCl).  Ellipticity measurements were
performed in triplicate at 25°C using a quartz cuvette with a 0.1 cm pathlength.  Measurements
were made at 1 nm steps over the wavelength range 250 – 190 nm, and were corrected for buffer
contributions to the signal.  HucR secondary structure composition was calculated using the
secondary structure algorithm CDSSTR and protein reference set 7 provided by the authors (28-
32).  The goodness-of-fit was determined from the NRMSD value of 0.013.
For measurement of thermal stability, HucR was diluted to 0.05 mg/ml in CD buffer B
(20 mM potassium phosphate (pH 7), 8 µM EDTA, 0.2% glycerol, 3 mM KCl) and
measurements were made using a quartz cuvette with a 1 cm pathlength.  Ellipticity readings
from 230 – 200 nm (1 nm steps) were taken over the temperature range 19 – 70°C, with steps of
3°C (19 - 37°C and 61 - 70°C) or 1.5°C (37 – 61°C).  Each sample also underwent a reverse scan
from 67 – 19°C.  Three minutes was allowed for thermal equilibration after each step.
Wavelength scans from 240 – 200 nm were performed at 19°C and 70°C to verify the native and
denatured states of HucR, respectively.  CD measurements of HucR melting were performed in
triplicate and corrected for buffer contributions to the signal.  Calculation of the Tm of HucR was
made based on ellipticity measurements from 224 – 220 nm.  Temperature dependent ellipticity
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values were plotted at each wavelength and fit to a two state model for protein unfolding (33).
The Tm of HucR is reported as the average ± standard deviation.
HucR-hucO Stoichiometry and Affinity Determination
Primers were designed according to the D. radiodurans  genome to amplify a 241 bp
segment that included the entire intergenic region between hucR and dr1160 and extended 61 bp
and 79 bp into the coding region of each gene, respectively.  The resulting PCR product, hucO,
was gel purified and 32P-labeled with T4-polynucleotide kinase (T4-PNK).
For binding assays under stoichiometric conditions, 0.1 µM 32P-labeled hucO was titrated
with HucR up to 0.35 µM, in a total reaction volume of 10 µl in Binding Buffer (20 mM Tris-
HCl (pH 8), 0.1 mM Na2EDTA, 0.075% BRIJ58, 50 mM NaCl, 5 mM MgCl2, 50 µg/ml BSA,
and 4% (v/v) glycerol).  Protein-DNA complexes were equilibrated at 22°C for 1 hour.  A non-
denaturing 6.5% polyacrylamide gel was pre-run for 30 minutes in 0.5xTBE buffer (45 mM Tris-
borate (pH 8.3), 1.25 mM Na2EDTA) and samples were loaded with the power on.  After 1.25
hours of electrophoresis the gels were dried and protein-DNA interactions analyzed by
phosphorimaging using a STORM 840 phosphorimager and ImageQuant 1.1 software.
Fractional complex formation was plotted against ([HucR]/[hucO]) and fit to a spline curve.
Tangents were generated from data points in the upward slope and the plateau, and the
stoichiometry of HucR:hucO complex formation extrapolated algebraically.  Experiments were
performed in duplicate.
EMSAs for Kd determination were performed as described above, except that binding
reactions involved 0.1 nM 32P-labeled hucO titrated with HucR up to 30 nM. The binding
isotherm for Kd determination was generated by non-linear fit of three data sets to the binding
equation: normalized fractional saturation of hucO = (n(P)/Kd)/(1 + (P/Kd)) where n is the
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number of HucR binding sites, P is free protein concentration, and Kd is the observed
equilibrium dissociation constant.  The Kd value is reported as the mean ± standard deviation.  In
the competition assay, binding conditions were as described above, involving 0.1 nM 32P-labeled
hucO titrated with up to 10 nM of unlabeled hucO or pGEM5.  HucR was added last to the
binding reactions, at a final concentration of 1 nM.
Methidiumpropyl-EDTA (MPE)-Fe(II) and DNaseI Footprinting
Complimentary 77-mer oligonucleotides were gel purified and the “top” strand was 5'-
end-32P-labeled with T4-PNK.  Annealing of the oligonucleotides was accomplished by slow
cooling from 90°C to 16°C.  Binding reactions were in a total volume of 10 µl and included 500
fmol of DNA in modified Binding Buffer with 0.06% BRIJ58, 20 µg/ml BSA, and 1.5%
glycerol.  Protein-DNA complexes were equilibrated for 1 hour at 22°C.  For MPE-Fe(II)
footprinting, 1 µl of 10 mM sodium ascorbate was added followed by 2 µl of MPE mix (25 µM
MPE,  25 µM FeNH4SO4), and digestion allowed to proceed for 2 minutes at room temperature.
DNaseI footprinting samples were incubated with 10-3 to 10-2 units of DNaseI (Epicentre) for 30
seconds at room temperature.  Digestion was terminated by phenol-chloroform extraction and
samples were ethanol precipitated.  A/G chemical sequencing ladders were generated according
to Sambrook et al. (34).  DNA fragments were separated on a 12% polyacrylamide sequencing
gel.  Density profiles were obtained by phosphorimaging.
Ligand Binding Assays
A 180 bp sequence spanning bp -158 to +22 relative to the hucR translational start site
(bp -76 to +104 relative to the predicted dr1160 transcriptional start site) was amplified, gel
purified, and 32P-labeled with T4-PNK.  For each ligand assayed, binding conditions were
established to buffer pH effects from the compound.  Binding reactions were assembled in
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Binding Buffer with 0.1 nM DNA, 0.75 nM HucR, and up to 25 mM sodium salicylate.  EMSA
were also performed without BSA in the Binding Buffer, with no detectable effect.  For
acetylsalicylate assays, acetylsalicylate was dissolved in ethanol and binding reactions were
assembled in modified Binding Buffer with 400 mM Tris-HCl (pH 8) and 20% ethanol with up
to 25 mM of  the compound.  Uric acid was dissolved in 0.35 M NaOH to a concentration of 125
mM.  Binding reactions were assembled in modified Binding Buffer with 500 mM Tris-HCl (pH
8), 0.05% BRIJ58, 7.5 µg/ml BSA, and 0.6% glycerol with up to 20 mM uric acid.  Reactions
were equilibrated for 1 hour at 22°C and protein-DNA complexes were analyzed by EMSA as
described above.  All experiments were carried out in triplicate.  Data was fit to a single
exponential equation:  normalized fractional complex formation = e-kL, where k is the
exponential decay constant and L is the ligand concentration.
RNA Dot Blot Hybridization
Ten µl of an overnight culture of D. radiodurans was added to 5 ml of TGY broth (0.5%
tryptone, 0.3% yeast extract, 0.1% glucose) or 5 ml of TGY broth supplemented with 10 mM
uric acid.  Before inoculation, the pH of broths containing uric acid was adjusted to that of TGY
broth.  Cultures were grown at 30°C to A600 = 0.45 and cells were harvested by centrifugation at
4°C at 12,000g for 10 minutes and stored at -80°C.  Pellets were resuspended in 3 ml of 95%
ethanol and held at 4°C for 10 minutes and harvested by centrifugation at 4°C at 12,000g for 10
minutes.  Total RNA was prepared as described (35).  DNA contamination was removed by
digestion with 1 µg RNase-free DNaseI (Epicentre) at 37°C for 1 hour.
RNA dot blots were performed essentially as described (35).  For each RNA sample, 15
µg was adhered to a (+)-charged nylon membrane using a Bio-Dot microfiltration apparatus
(Bio-Rad) and crosslinked using a Stratalinker UV crosslinker (Stratagene) at 120,000 µJ/cm2 for
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50 seconds.  Oligonucleotide probes complementary to the dr1160 transcript (+30 to +49 relative
to the predicted start site of translation) and to the hucR transcript (+21 to +40 relative to the start
site of translation) were used.  As groESL (dr0606-0607) expression in D. radiodurans has been
shown to be constitutively expressed under different growth conditions, a probe was designed
complementary to residues +310 to +330 of groES to serve as a normalizing factor for RNA
samples (36).  The probes were 32P-labeled with T4-polynucleotide kinase, separately hybridized
to the crosslinked membranes overnight and washed under moderate conditions, as described
(35).  The densitometric count obtained with the dr1160 or hucR probe for each RNA sample
was normalized by multiplying by the ratio of sample 32P-groES counts to control RNA 32P-
groES counts.  RNA dot blot analysis was performed in duplicate from separate RNA
preparations.  The levels of hucR and dr1160 transcript from cells grown in 10 mM uric acid are
reported as the mean ± standard deviation relative to the transcript level from control cells.
Analysis of Uricase Activity
D. radiodurans was grown in TGY or TGY + 10 mM uric acid as described above.  Cell
pellets were resuspended in chilled HAP buffer, pH 7.5 without 2-mercaptoethanol and lysed by
sonication.  Insoluble material was removed by centrifugation at 4°C.  Protein concentrations of
whole cell lysates were determined from a BSA standard using the modified Lowry protein assay
(Pierce).
Uricase activity in the whole cell lysate was analyzed using an Amplex Red Uric
Acid/Uricase Assay Kit (Molecular Probes).  Each reaction included 45 µg of whole cell lysate
protein.  Uricase activity is normalized to the activity recorded for cells grown in absence of
added uric acid and is reported as the mean ± standard deviation (n = 5).
47
Results
The hucR Regulatory Region
Locus dr1159 in chromosome I of D. radiodurans encodes a putative 181 residue, 19.7
kDa MarR homolog.  An intergenic region of 101 bp separates dr1159 from the oppositely
oriented ORF of a hypothetical uricase (dr1160) (Fig. 2.1).  Pairwise alignment of the predicted
protein product of dr1160 with a characterized uricase from Bacillus subtilis indicates 29.5%
identity and 54% similarity, suggesting that the D. radiodurans homolog is functional (37).
Uricase catalyzes the conversion of uric acid into allantoin during purine catabolism, and its
activity is correlated with oxidative stress response in mammals (38, 39).  A downstream locus,
dr1161, encoding a hypothetical, transthyretin-like protein is oriented in the same direction as
dr1160, with the ORFs overlapping by one codon.  A study of D. radiodurans promoter elements
indicated a strong similarity to the E. coli σ70 consensus -10 and -35 regions, amongst the
promoters surveyed (40).  We identified σ70-like promoter elements for dr1159 and dr1160 in
the sequence between these two genes.  These promoter regions are partially overlapping, with
the putative transcription initiation site of each gene positioned in the Pribnow box of the other.
The spacing and orientation of the hypothetical MarR homolog encoded at locus dr1159, relative
to the ORFs of dr1160 and dr1161 suggested a potential regulatory design analogous to systems
observed with other MarR proteins, such as MexR from P. aeruginosa and HpaR from E. coli (8,
12).  We were therefore prompted to designate dr1159 as hucR for hypothetical uricase regulator.
Sequence and Structural Analysis of HucR
Pairwise alignment of the amino acid sequence of HucR with the prototype of this family,
MarR, reveals 29% identity and 49% similarity between these two proteins.  Pairwise alignment
with other characterized MarR regulators shows that HucR shares higher homology with EmrR
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Fig. 2.1. The genetic organization of dr1159 and adjacent ORFs.  The relative orientations of
the ORFs are represented by open arrows.  HucR is encoded by dr1159, dr1160 encodes a
hypothetical uricase, and dr1161 encodes a transthyretin-like protein.  An intergenic region of
101 bp separating hucR and dr1160/dr1161 contains putative σ70 -10 and -35 promoter elements
for each gene, designated by bars above (dr1160/dr1161) or below (dr1159) the sequence.
Predicted transcription and translation start sites are identified by asterisks and arrows,
respectively.  The shaded box marks the HucR binding site.  Each half-site of the
pseudopalindromic sequence within the binding site is identified in bold.
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and MexR, demonstrating 34% identity with each, and 55% and 49% similarity with these
repressors, respectively.  Multiple sequence alignment of HucR with eight representative MarR
homologs reveals seven identical residues in the C-terminal half of these proteins (Fig. 2.2).
Five of these sites (residues 118, 124, 126, 132, and 133) occur within the β-sheet and turn
structural elements of MarR that form the “wing 1” motif, and a sixth identical residue lies in an
α-helix immediately adjacent to this region (22, 41).  The wing 1 structural element of the
winged helix motif flanks the DNA recognition helix, and has been shown to make direct
contacts with DNA, in either the minor or major groove (41).  Of the 14 residues identified from
the MarR crystal structure to form the hydrophobic core of the monomeric DNA binding
domain, 10 are conserved or identical in the MarR homologs analyzed (22).  Direct comparison
of HucR and MarR reveals that 5 of these residues are identical and an additional 6 are
conserved.
The residues in the MarR monomer that were shown to make contacts with the two
salicylate ligands are highly conserved in HucR.  In ligand binding site “A” of MarR, Thr104
hydrogen bonds with the salicylate hydroxyl, Arg118 hydrogen bonds with the salicylate
carboxylate, and Pro89 is located within 3.5 Å of the unsubstituted side of the salicylate ring.  In
HucR, Arg118 and Pro89 are conserved, while serine replaces threonine at position 104.  Arg109
in MarR, which is conserved in HucR, hydrogen bonds to the salicylate carboxylate group in site
“B” of MarR.  Val128 of MarR is positioned 3.6 Å above the salicylate ring in site “A” of the
adjacent half of the dimer.  This valine is replaced by alanine in HucR.
The coding region of hucR was cloned into a pET5a expression vector and the product,
HucR, was purified to greater than 95% homogeneity, as revealed by SDS-PAGE (Fig. 2.3).  The
far-UV circular dichroism spectrum from 250–190 nm was recorded at 25°C to determine the
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Fig. 2.2.  Multiple sequence alignment of HucR and representative MarR family members.
The alignment was generated using ClustalX and conserved residues were colored using
MacBoxshade.  Numbering is based upon the HucR sequence.  Residues that are identical in all
nine homologs are shaded red.  Residues that are ≥ 80% conserved are shaded blue/green, where
green indicates non-identity to the HucR residue at that position.  Plus signs above the sequence
designate residues identified from the MarR crystal structure to form the hydrophobic core of the
monomeric DNA binding domain (22).  The helix-turn-helix DNA-binding motif, and flanking
β-sheet and “wing 1” region identified from the MarR crystal structure, are designated below the
alignment.  Numbering of the secondary structural elements is as reported for MarR, with α4
being the DNA recognition helix.  Proteins are HucR from D. radiodurans R1, a homolog from
Sinorhizobium meliloti (NP_384406), two homologs from Agrobacterium tumefaciens
(NP_530978 labeled as “1” and NP_353303 as “2”), EmrR from E. coli (P24201), MexR from P.
aeruginosa (C83593), PecS from Erwinia chrysanthemi (P42195), MarR from E. coli (P27245),
and HpaR from E. coli (Q07095).
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Fig. 2.3.  Purified HucR.  HucR was purified to > 95% homogeneity.  Lane 1, molecular mass
marker, in kDa; lane 2, 1 µg of purified HucR.  Monomeric HucR migrates at approximately 19
kDa, close to its predicted molecular mass of 19.7 kDa.
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secondary structure composition of HucR (Fig. 2.4).  The α-helical and β-sheet content for HucR
was calculated to be approximately 47% and 10%, respectively, with 17% turns and 25% random
coil (28-32).  In comparison, the crystal structure of MarR revealed its composition to be ~58%
helical and 10% β-sheet (22).  The MexR crystal structure also revealed a large α-helical content
and a relatively small β-sheet contribution (42).  Ellipticity measurements at five wavelengths
spanning the negative ellipticity maximum characteristic of α-helices (220–224 nm) were
recorded over the temperature range of 19 - 70°C and plotted to measure protein denaturation
(Fig. 2.4B).  From the CD melting curve, the Tm of HucR was calculated to be 51.1 ± 0.0 °C.
HucR did not refold during the reverse temperature scan, so ∆H° values for folding transitions
could not be determined.
Binding of HucR to its Promoter/Operator Region
Given the prevalence of autoregulatory MarR transcription factors, we biochemically
assessed HucR for such a capacity.  To test the affinity of HucR for its promoter/operator region
(hucO), we amplified a 241 bp region of the D. radiodurans genome, extending from 180 bp
upstream of the putative hucR translation start site to 61 bp within the coding region.  EMSA
revealed HucR to have high affinity for hucO, with an apparent Kd of 0.29 ± 0.02 nM (Fig. 2.5)
and a concomitant ∆Gassoc. of -12.9 kcal/mol.  The single complex observed, and the goodness of
fit to a single-site binding polynomial, suggested that HucR binds hucO at a single site. The
specificity of this interaction was verified by the inability of pGEM5 to compete for HucR
binding (Fig. 2.5B).  Complex formation between 1 nM HucR and 0.1 nM 32P-labeled hucO was
reduced to half saturation at approximately 1 nM unlabeled hucO, whereas only a minor
reduction in complex formation was elicited by 10 nM pGEM5.  As pGEM5 contributes an
approximately twelve-fold greater molar excess of base pairs than hucO, the competition assay,
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Fig. 2.4.  CD spectral analysis of HucR.  A,  Far-UV CD spectrum of HucR at 25°C.  Ellipticity
measurements are expressed in machine units (millidegrees).  B,  Thermal unfolding transition of
HucR.  Ellipticity measurements were collected over the temperature range of 19 - 70°C at five
wavelengths spanning the negative ellipticity maximum characteristic of α-helices:  () = 220
nm, () = 221 nm, (❏) = 222 nm, () = 223 nm, and () = 224 nm.
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Fig. 2.5.  HucR binding to its promoter/operator region, hucO.  A,  EMSA.  0.1 nM hucO was
titrated with HucR.  Uncomplexed hucO and the single hucO:HucR complex are identified by
arrows.  Protein concentrations are indicated above the corresponding lanes.  B,  Competition
assay.  0.1 nM of labeled hucO and 1 nM HucR was titrated with up to 10 nM of either unlabeled
hucO or pGEM5 and complexes resolved by EMSA.  The first lane contains only labeled hucO.
Concentrations of unlabeled competitor DNA are indicated above the corresponding lanes.
Complexed and uncomplexed hucO are identified by arrows.  C, Binding isotherm depicting
normalized hucO fractional saturation as a function of uncomplexed HucR.  Data were collected
in triplicate.  D,  Stoichiometry of HucR:hucO complex formation.
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in conjunction with footprinting analyses (see below), unequivocally demonstrates site specific
binding of HucR and hucO.  From EMSA performed under stoichiometric conditions, HucR was
shown to bind hucO at a ratio of 1.85:1, suggesting that HucR binds its promoter/operator region
as a dimer (Fig. 2.5D).  This finding is consistent with crystallographic and biochemical analyses
of other MarR homologs which have also been shown to form homodimers (13, 22, 42).
Methidiumpropyl-EDTA-Fe(II) (MPE-Fe(II)) and DNaseI footprinting was performed
using the top strand of a 77 bp hucO fragment.  MPE-Fe(II) footprinting revealed the HucR
dimer to protect 21 bp of hucO spanning the region from -19 to +3 relative to the putative uricase
(dr1160) transcriptional start site (Fig. 2.6).  The footprint was extended by partial protection of
bp -20 and -21.  The footprint generated by DNaseI (Fig. 2.6) shows protection from -18 to +6,
relative to the uricase transcriptional start site.  Analysis of the DNaseI footprint also revealed
sites of hypersensitive cleavage flanking each end of the HucR dimer binding site (+8, +7, and -
19), suggesting that HucR distorts hucO upon binding.  Winged helix proteins from the MarR
family characteristically bind as dimers to inverted repeat sequences in their cognate recognition
sites (12).  Footprinting analysis revealed the HucR dimer binding site within hucO to contain an
imperfect 8 bp inverted repeat, with two bp separating each half of the palindrome (Fig. 2.1).
Ligand Binding Assays
Members of the MarR family of transcriptional regulators are natural phenolic sensors,
and hence play critical roles in environmental surveillance.  Given the significant conservation in
HucR of residues that are involved in binding salicylate in MarR, we tested this anionic
lipophilic compound as a potential ligand of HucR.  Normalized fractional HucR:hucO complex
formation was analyzed as a function of sodium salicylate concentration (Fig. 2.7).  Sodium
salicylate antagonized the binding of HucR to hucO, with 5.2 mM of the compound reducing the
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Fig. 2.6.  Footprinting analysis of HucR:hucO complex.  A,  DNaseI (lanes 1 – 3) and MPE-
Fe(II) (lanes 4 – 9) footprinting of top strand of hucO.  Lanes 1 and 4,  A/G ladder ; lane 2,
DNaseI treatment of hucO in the absence of HucR ; lane 3,  DNaseI treatment of hucO incubated
with 200 nM HucR.  Lanes 5 -9,  MPE-Fe(II) treatment of hucO after incubation with 0 nM, 25
nM, 100 nM, 200 nM, or 400 nM HucR, respectively.  The predicted positions of the dr1160 -10
promoter element and transcriptional start site are indicated at the right.  B,  Densitometric
profile of the HucR:hucO complex, as determined by MPE-Fe(II) footprinting.  MPE-Fe(II)
treated hucO in the absence of HucR is represented by the gray trace.  The dark line represents
DNA incubated with 200 nM HucR (lane 8 in panel A).  C,  Densitometric profile of the
HucR:hucO  complex, as determined by DNaseI footprinting.  The gray line shows the
densitometric trace of DNaseI treated hucO, in the absence of HucR.  DNaseI cleavage of hucO
incubated with 200 nM HucR is represented by the dark trace.  Sequence numbering in panels A
– C is relative to the predicted +1 transcriptional start site of dr1160, as in Fig. 2.1.
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Fig. 2.7.  HucR effector binding assays.  A,  Structures of the compounds tested:  salicylic acid,
acetylsalicylic acid, and uric acid (shown in its more stable keto tautomeric conformation).  B,
EMSA demonstrating the capacity of uric acid as a negative effector of HucR binding to its
cognate DNA-binding site.  Uric acid concentrations (in mM) are shown above the
corresponding lanes.  Bands corresponding to free hucO and hucO:HucR complex are marked by
arrows.  Lane 1,  hucO incubated with 15 mM uric acid in the absence of HucR.  C,  Normalized
hucO:HucR complex formation as a function of ligand concentration.  Experiments were
performed in triplicate.  () = sodium salicylate ; () = acetylsalicylate; (◊) = uric acid.
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normalized fractional saturation to 0.5.  At 25 mM sodium salicylate, the fraction of  complexed
hucO approached zero.  As BSA is known to bind salicylate, it was possible that, due to the BSA
in the binding reaction, salicylate’s antagonistic effect on HucR:hucO interaction was greater
than we observed.  However, removal of BSA from the binding reactions resulted in no
observable change in salicylate’s role as a negative effector of HucR (data not shown).
Acetylsalicylate was suggested to induce transcription of the marRAB operon in vivo, yet
in vitro analysis suggested that acetylsalicylate does not bind MarR (16, 18).  Acetylsalicylate
caused a gradual decrease in complexed hucO with increasing drug concentration, however, even
at 25 mM acetylsalicylate, the normalized fractional saturation of hucO remained at ~0.6.
Approximately 46 mM acetylsalicylate is required to reduce the fractional saturation to 0.5.
Therefore, an acetyl group esterified to the 2-hydroxyl of salicylate decreases by 9-fold the
negative effector capacity of the ligand.
The apparent phenolic sensing capability of HucR, and its high affinity for a site within
the promoter/operator region of a putative uricase (Fig. 2.1), suggested a potential catabolic
regulatory system in which HucR regulation of uricase expression is responsive to levels of uric
acid, the substrate for this enzyme.  Like salicylic acid, uric acid is a planar, aromatic compound,
but consists of two conjugated ring systems.  As seen in Fig. 2.7, uric acid is a potent regulator of
HucR; the normalized fraction of complexed hucO approached zero at ~1 mM uric acid, with
0.26 mM uric acid being sufficient to reduce the normalized fractional complex to 50%.  Uric
acid is therefore an approximately 20-fold stronger antagonist of HucR:hucO interaction than
salicylate, and over 175-fold stronger than acetylsalicylate.  This pronounced attenuation of
complex formation elicited by uric acid, relative to the effects observed from the other aromatic
compounds, suggests that this compound is the natural ligand of HucR.
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In vivo Analysis of Gene Regulation by HucR
The in vitro investigations described above are consistent with a model in which
transcription of hucR and dr1160 (putative uricase) is regulated by the high-affinity interaction
of HucR in the intergenic region.  The dramatic reduction in HucR:hucO affinity educed by uric
acid suggests that this compound would weaken HucR-mediated repression.  Furthermore, the
homology between the hypothetical enzyme encoded by dr1160, the only putative uricase in the
D. radiodurans genome, and the characterized uricase from B. subtilis suggests that this gene
encodes a functional enzyme (37).  We investigated this model through a combination of RNA
dot blot hybridization and uricase activity experiments.
Transcript levels of hucR and dr1160 were compared from D. radiodurans grown in the
presence versus absence of 10 mM uric acid (Fig. 2.8A).  RNA dot blot hybridization of a 32P-
labeled probe complementary to the sense strand of hucR revealed a higher level of transcript in
cells grown in 10 mM uric acid, at a ratio of 1.6 ± 0.1 relative to control cells.  Hybridization of a
probe complementary to the sense strand of dr1160 revealed upregulation of the putative uricase
in the cells grown in 10 mM uric acid, at a ratio of 1.6 ± 0.0 relative to control cells.
A coupled enzymatic assay was performed to assess uricase activity in protein from
whole cell lysate of cells grown in the presence versus absence of 10 mM uric acid (Fig. 2.8B).
The assay links the activity of uricase from the samples to the activity of horseradish peroxidase,
producing resorufin, which has an absorption maximum near 560 nm.  Uricase activity was
detected in cells supplemented with or without uric acid, suggesting that dr1160 does indeed
encode a functional uricase.  Uricase activity was 1.5 ± 0.0 times higher in cells grown in the
presence of 10 mM uric acid compared to its absence.  The enhanced levels of hucR and dr1160
transcript and the elevated uricase activity in cells grown in excess uric acid is consistent with
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Fig. 2.8.  Analysis of hucR and dr1160 (uricase) gene expression.  A,  Expression of hucR and
dr1160 in log-phase cells grown in the absence (black bars) or presence (cross-hatched bars) of
10 mM uric acid, as determined by RNA dot blot analysis.  Transcript levels of hucR and dr1160
were calculated using radiolabeled probes complementary to the sense strand of the respective
gene, as indicated on the x-axis.  The transcript levels of uric acid supplemented cells are
reported relative to those of control cells.  The error bars indicate the standard deviations from
two experiments.  B,  Analysis of uricase activity in log-phase cells grown in the absence (black
bars) or presence (cross-hatched bars) of 10 mM uric acid.  Uricase activity is measured by the
absorbance of resorufin at 560 nm.  Activity in uric acid supplemented cells is reported relative
to that in control cells.  The error bar indicates the standard deviation from five experiments.
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the in vitro ligand binding studies with HucR, and strongly support a model in which
transcription of these two divergent genes is de-repressed by the effector uric acid.
Discussion
The identification of MarR homologs within the D. radiodurans genome suggested the
presence of uncharacterized regulatory systems responsive to phenolic compounds within this
stress-resistant microorganism. In this study, we demonstrate that HucR binds with very high
affinity (Kd = 0.29 ± 0.02 nM)  at a single site in its regulatory region (Fig. 2.5 and 2.6).  In
comparison, E. coli MarR binds its cognate site with an apparent Kd of 1 nM and the winged
helix protein, Ptr1, binds its cognate sites with apparent Kd values of 1-2 nM (18, 43).  Winged
helix proteins from the MarR family characteristically bind to sites containing palindromic, or
pseudopalindromic sequences.  HpaR, for example, binds to sequences possessing two 9 bp half-
sites separated by 2 bp and CinR binds to a 16 bp palindrome composed of two adjacent 8 bp
half-sites (8, 14).  The binding site of EmrR contains an imperfect 9 bp inverted repeat with each
half-site separated by 3 bp (10).  The binding site for HucR contains an imperfect 8 bp inverted
repeat, with each half-site separated by 2 bp (Figs. 2.1 and 2.6).  The center of each half-site of
the palindrome is therefore separated by 10 bp, thus positioning the binding site for each half of
the HucR homodimer on the same face of the double-helix.  This contrasts with the binding site
of MarR, which contains two inverted 5 bp sequences separated by 2 bp, thus positioning the
half-sites on different faces of the double helix (18). In the case of MexR, the 5 bp inverted
repeat sequences are separated by 5 bp, which would orient the major groove of each half-site on
the same face of the DNA helix (12). There is variation within the winged helix family in the
mode of DNA binding, but the recognition helix typically makes most of the sequence-specific
contacts within the major groove (38, 44).  It is therefore likely that HucR shares a similar mode
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of DNA binding with its two closest, characterized homologs, EmrR and MexR, in which the
recognition helix of each half of the homodimer binds in the major groove on the same face of
the double-helix.
A number of autoregulatory members of the MarR family have been described, including
repressors that, like HucR, are not encoded in a contiguous operon.  The position of the HucR
binding site in hucO suggests a mechanism of simultaneous transcriptional repression of the
divergent hucR and uricase genes, involving steric inhibition of RNA polymerase recruitment to
the promoter or elongation.  The orientation of hucR and the uricase gene, with an intervening
regulatory region, is similar to the genetic organization of other MarR homologs.  For example,
MexR binds to two sites in the mexR-mexA intergenic region, with each binding site containing
promoter elements of each gene, explaining the mechanism of MexR repression (12).  HpaR
regulates its own expression, and that of an oppositely oriented gene cluster, by binding in the
central operator/promoter region (8).
Our finding that salicylate is a negative effector of HucR:hucO interaction is consistent
with HucR’s conservation of residues that form the salicylate binding site in MarR (Fig. 2.7)
(22).  The decreased affinity of HucR (and MarR) for acetylsalicylate is likely due to the extra
acetyl group and the concomitant loss of hydrogen bonding capacity with Ser104 (Thr104 in
MarR) (18).  An explanation of HucR’s apparent higher affinity for uric acid compared to
salicylate awaits structural details of this protein.   The efficient antagonism of HucR:hucO
interaction by uric acid suggests a regulatory mechanism of uric acid catabolism (Fig. 2.7).
Several repressors of aromatic catabolic pathways from the MarR family have been characterized
(45).  For instance, HpaR represses the transcription of genes involved in the catabolism of 4-
hydroxyphenylacetic acid, and this repression is relieved by the binding of the substrate, 4-
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hydroxyphenylacetic acid, to HpaR (8).   The repression of a cinnamoyl ester hydrolase by CinR
is relieved by aromatic substrates of this enzyme (14).  The catabolism of uric acid in D.
radiodurans is likely regulated in an analogous manner, with uric acid directly relieving HucR
mediated repression of uricase levels in the cell.  This model of co-repression of hucR and
dr1160 (predicted uricase) is supported by RNA dot blot analysis which reveals uric acid-
induced upregulation of both genes to similar transcript levels in D. radiodurans (Fig. 2.8A) and
by the upregulation of uricase activity in the presence of excess uric acid (Fig. 2.8B).  As dr1160
is the only uricase homolog in the D. radiodurans genome, we interpret these results as support
of a model of HucR mediated regulation.
The physiological significance of uricase regulation in D. radiodurans is unclear.  This
enzyme acts as part of the purine degradation pathway in prokaryotes and in eukaryotes. In
primates, birds, terrestrial reptiles, and many insects, uric acid is the final product of purine
catabolism, and is excreted into the environment. Selected soil bacteria are capable of
catabolizing uric acid as a carbon and energy source, including strains of Bacillus fastidiosus,
which require uric acid (or its degradation products allantoin and allantoic acid) as a substrate for
growth (46).  B. subtilis can utilize uric acid as its sole nitrogen source (47).  As D. radiodurans
is also a soil dwelling microorganism, it is tempting to speculate on the possibility that it, too,
has acquired the capacity to use uric acid as a source of carbon, energy, or nitrogen.
Analysis of 16S ribosomal DNA sequences suggests that Deinococcus forms a separate
bacterial phylum with the thermophilic Thermus genus (48).  However, the Tm of 51.1 ± 0.0°C
for HucR, is similar to the Tm values (at similar salt concentrations) of other helix-turn-helix
transcriptional regulators from mesophilic organisms, such as the LacI DNA-binding domain,
which has a Tm of 45.6 ± 0.2°C and the DNA-binding domain of MATα2, which has a Tm of
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56.5°C (49, 50).  Despite the close relationship of Deinococcus to a thermophilic genus, HucR
does not appear to be an unusually thermostable protein.  HucR shares the highest sequence
similarity to uncharacterized MarR homologs from Sinorhizobium meliloti and Agrobacterium
tumefaciens (Fig. 2.2), both of which are soil dwelling, mesophilic, plant symbionts from the
family Rhizobiaceae.  This family is grouped with the Proteobacteria, a eubacterial lineage that
is distantly related to Deinococcus.  Pairwise alignment of HucR and its homolog from
Sinorhizobium shows 38% sequence identity and 55% similarity.  Alignment with each of the
Agrobacterium homologs reveals 36.5% identity and 55.7% similarity.  As D. radiodurans is a
soil dwelling mesophile, it is plausible that HucR’s similarity to these Rhizobial proteins is a
result of horizontal gene transfer (25).  Multiple genes in D. radiodurans appear to have been
acquired via horizontal transfer, including at least seven stress response genes that were likely
acquired from species belonging to the family Rhizobiaceae (25).  HucR’s potential role in
regulating uric acid levels, suggests that it, too, is involved in D. radiodurans stress response.
Uric acid is an efficient scavenger of reactive oxygen species, including hydroxyl radicals,
superoxide anion, and singlet oxygen and is thought to be a critical antioxidant in mammals (51,
52).  Indeed, D. radiodurans demonstrates extreme resistance to oxidative damage (53-55).
HucR mediated regulation of uric acid levels in D. radiodurans could therefore contribute to this
organism’s observed resistance to high levels of oxidative stress.  It has been demonstrated that
oxygen increases the lethality of ionizing radiation in D. radiodurans presumably by generating
reactive oxygen species (56).  By regulating levels of uric acid, HucR could therefore also
participate in the response of D. radiodurans to ionizing radiation. It is likely that the sensitivity
of HucR activity to levels of uric acid serves to maintain an optimum level of this scavenger of
peroxynitrite and other reactive oxygen species in the cytoplasm.  The low solubility of uric acid
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is well documented and is manifested in precipitate-related health problems such as gout in
humans.  Other proteins in this family have been shown to regulate resistance to oxidative stress,
including MarR, SlyA, and OhrR (57-59).  PecS control of indigoidine, an apparent radical
scavenger, regulates E. chrysanthemi resistance to reactive oxygen species (7).  It is thus
tempting to speculate that HucR shares with these MarR homologs a common functional role of
mediating oxidative stress response.
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NEGATIVE COOPERATIVITY OF URIC ACID BINDING IN THE DNA-
BINDING DOMAIN OF HUCR
Introduction
The identification of the MarR (multiple antibiotic resistance regulator) family of
transcriptional regulators was initiated by genetic experiments that identified strains of
Escherichia coli K-12 with enhanced resistance to structurally diverse antibiotics, oxidative
stress agents, and organic solvents (1-5). The locus responsible for the resistance phenotype was
identified as the marRAB (multiple antibiotic resistance) operon (6, 7). Transcriptional repression
was shown to be conferred by the product of the first gene of this operon, MarR, which binds
with high affinity (Kd ∼1 nM) as a homodimer to two sites in the marRAB promoter/operator
region (4, 8). MarR-mediated repression was shown to be relieved, both in vitro and in vivo, by
structurally diverse phenolic compounds, including some of the antimicrobial agents to which
the operon confers resistance (4, 9-11). Structural determination identified MarR as a winged
helix DNA-binding protein (12).
Numerous prokaryotic MarR homologs have since been identified with physiological
regulatory roles in antibiotic and oxidative stress response (MarR, MexR, EmrR, PecS, HucR),
the production of virulence factors (PecS), and the catabolism of aromatic compounds (HpaR,
HpcR, CinR, BadR, CbaR, HucR) (9, 13-17). The DNA-binding capacities of a number of these
MarR family members have been shown to be altered by anionic lipophilic compounds, often by
the suggested target of the regulated genes.
The structure of the MarR dimer bound to the effector salicylate has been determined at
2.3 Å resolution, revealing two ligand binding sites, designated as SAL-A and SAL-B, on either
side of the proposed DNA recognition helix (12). The proximity of the ligand-binding sites in
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MarR to residues shown to be critical for MarR binding activity suggested a potential mechanism
of regulation (18). In addition, the crystal structure of a MarR family member, MexR from
Pseudomonas aeruginosa, has been solved at a resolution of 2.1 Å (19). Several conformational
states of the MexR dimer were observed in the asymmetric unit, suggesting that the mechanism
of ligand-induced effects on the DNA binding activity of this protein involves alterations to the
relative orientations of the DNA binding domains from each half of the dimer. However, without
combined structural data for each protein in its DNA-bound, ligand-bound, and apo-
conformations, the DNA-binding and ligand-response mechanisms of these MarR homologs
remain unknown.
We previously reported the biochemical characterization of HucR, a novel MarR
homolog from Deinococcus radiodurans (17). HucR binds as a homodimer with very high
affinity (Kd = 0.29 nM) to a single 21 bp site containing E. coli σ
70-like promoter elements
driving its own expression and that of an adjacent, putative uricase (dr1160). The affinity of
HucR for its cognate binding sequence is antagonized by certain anionic lipophilic compounds,
most notably uric acid. Analyses in vivo indicate that uric acid upregulates transcription of hucR
and dr1160 in D. radiodurans and suggest that uricase activity in D. radiodurans total protein
extracts is increased in cells grown in the presence of uric acid.
In this study, we provide the first biochemical investigation into the mechanisms of DNA
interaction and ligand response for a member of the MarR family. Spectroscopic evidence
reveals that the mechanism by which HucR binds its sequence-specific DNA binding site
involves conformational flexibility in both the protein and in the DNA helix. We show that HucR
possesses at least two uric acid binding sites with dissimilar ligand-binding affinities. Moreover,
our data suggest that the highly conserved ligand-binding site corresponding to SAL-A in MarR
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is a weak ligand-binding site in HucR, indicating that uric acid’s antagonistic effect on HucR-
DNA interaction is not mediated primarily by site SAL-A.
Experimental Procedures
Circular Dichroism (CD) Spectroscopy
Complimentary synthetic oligonucleotides were gel purified and annealed to generate a
31 bp fragment (hucO-31) containing the HucR binding site, spanning the sequence -23 to +8
relative to the putative transcriptional start site of dr1160. CD spectroscopy was performed on an
AVIV 202 CD spectrophotometer using a quartz cuvette with a 1 cm pathlength. DNA was
diluted to a final concentration of 2 µM in CD buffer (20 mM potassium phosphate, pH 7, 50
mM KCl) and titrated with concentrated HucR to a final concentration of 4 µM monomer. After
each titration, samples were equilibrated at 25°C for 15 minutes before data was collected.
Ellipticity measurements were collected at 25°C from 340 - 190 nm in steps of 1 nm. All data
was corrected for buffer contributions to the signal and samples containing HucR were corrected
for additional ellipticity contributions from the protein. Experiments were performed in duplicate
(with representative data reported from one experiment).
Intrinsic Fluorescence Measurements
Fluorescence emission spectra from 280 - 440 nm were recorded on a Jasco FP-6300
spectrofluorometer with an excitation wavelength of 280 nm at 25°C using a 0.5 cm pathlength
cuvette. All experiments were performed with 0.03 mg/ml protein (1.52 µM wild type or mutant
HucR) in 40 mM Tris-Cl, pH 8.0, 0.2 mM EDTA, 0.1% BRIJ58, 100 mM NaCl, and 10 mM
MgCl2, unless stated otherwise. Parallel absorbance spectra were recorded for each sample from
190 - 450 nm. For measurements of protein-hucO-31 complexes, HucR (wt or mutant) was
titrated with concentrated hucO-31, mixed, and equilibrated for 15 minutes before scanning. For
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the protein-ligand binding assays, stock solutions of uric acid, salicylic acid, and acetylsalicylic
acid were prepared as described (17). Serial ligand dilutions were prepared such that the addition
of 0.5 µl to the protein sample would attain the desired ligand concentration. Samples were
mixed and incubated for 60 seconds before each scan.
The corrected protein fluorescence intensity at each wavelength (Fcorr(λ)) was obtained
from the observed fluorescence by first correcting for dilution from titration and background
fluorescence to obtain Fc(λ). Inner filter effects were then resolved by the following correction
factor,
Fcorr(λ) = Fc(λ) x 10(Aex/2 + Aem/2)
where Aex and Aem are the absorbances at the excitation and emission wavelengths, respectively
(20). Fcorr(λ) is only reported for samples where both Aex and Aem are less than 0.2. For ligand
binding assays where Aex exceeded 0.2, normalized fluorescence intensities were obtained by
partial correction of the inner filter effect (Fpcorr(λ)),
 Fpcorr(λ) = Fc(λ) x 10(Aem/2)
before being normalized to the maximal Fpcorr. For fluorescence measurements involving
acetylsalicylic acid, Fc(λ) was calculated by incorporating an additional, experimentally
determined factor to correct for quenching resulting from the solvent, ethanol.
Percent quenching induced by DNA binding was calculated by:
%Q = 100(1 – (Fcorr(338 nm) {Protein + DNA} / Fcorr(338 nm) {Protein}))
For ligand binding at low ligand concentrations, quenching at 338 nm was calculated by:
quenching (338 nm) = 1 – (Fcorr[X] / Fcorr[0])
where Fcorr[X] and Fcorr[0] are the corrected fluorescence intensities at 338 nm for ligand
concentrations X µM and 0 µM, respectively. Uric acid binding isotherms were generated by
73
nonlinear fits to the Hill equation: quenching (338 nm) = {n(1/Kd)(U)
nH} / (1 + (1/Kd)(U)
nH),
where n represents the quenching plateau, U is uric acid concentration, Kd is the observed
dissociation constant, and nH is the Hill coefficient. Data are reported as the mean ± standard
deviation for two separate experiments.
Sedimentation Equilibrium
A 150 µl HucR sample at A280 = 0.65 was dialyzed overnight at 4°C against 350 ml of
AU buffer (20 mM Tris-HCl (pH 8.0), 50 mM NaCl, 5 mM MgCl2). The reference and solution
sectors of an analytical cell with a double-sector centerpiece were loaded with 125 µl AU buffer
and 110 µl HucR sample, respectively. Equilibrium analysis was performed at 20°C at 10,000
rpm using a Beckman Optima XL-A analytical ultracentrifuge equipped with a An-60 Ti rotor.
The cell was scanned at 5-hr intervals at 294 nm with a step size of 0.004 cm until the system
reached equilibrium. The partial specific volume of HucR at 20°C was determined to be 0.7387
cm3/g from the primary amino acid sequence using the program SEDNTERP, and the solution
density calculated to be 1.00120 g/cm3. Equilibrium sedimentation data were analyzed using
Origin Equilibrium software and fit to an equation describing a single ideal protein species.
Cloning, Overexpression, and Purification of HucR Mutants
Primers were designed to introduce the desired amino acid substitutions into the hucR
coding sequence via whole plasmid PCR using the recombinant plasmid pHucR, which contains
the hucR coding region as a template (17). Arginine 118 was converted to alanine using primers
R118A-FWD (5′- CTG ATC GAG GCC CGC GAG GAC -3′; nucleotide substitutions yielding
R118 → A in bold) and R118A-REV (5′- GCC CTT TTC GAG CAG CCG CAC- 3′). Serine
104 was converted to alanine using primers S104A-FWD (5′- CCT TCG ACG GCC AAC CGG
ATC -3′; nucleotide substitutions yielding S104 → A in bold) and S104A-REV (5′- CCC GGA
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AAT GGC GGC CAG G -3′). PCR products were treated with DpnI and transformed into E. coli
TOP10 (Invitrogen). The fidelity of the recovered plasmids, identified as pR118A and pS104A,
was verified by DNA sequencing. Plasmids pR118A and pS104A were individually transformed
into E. coli BL21(DE3)pLysS. HucR mutants were expressed, and cells lysed essentially as
described for wild type HucR, with the exception that protein expression was induced with 0.8
mM isopropyl-1-thio-β-D-galactopyranoside for 75 minutes (17). Cell lysates were precipitated
on ice with ammonium sulfate to 60% saturation and the resulting pellets resuspended in 100 ml
of the appropriate buffer: for HucR-R118A purification, HA buffer (20 mM Tris-HCl (pH 7.5),
50 mM KCl, 4.8% glycerol (v/v), 1 mM Na2EDTA, 4.3 mM 2-mercaptoethanol, 0.2 mM
phenylmethylsulfonyl fluoride) and for HucR-S104A purification, HAPT buffer (20 mM
potassium phosphate (pH 6.0), 50 mM KCl, 10% glycerol (v/v), 1 mM Na2EDTA, 0.02%
Tween-20, 4.3 mM 2-mercaptoethanol, 0.2 mM phenylmethylsulfonyl fluoride) and
subsequently dialyzed overnight against 40 volumes of the respective buffer (this and all
subsequent purification steps were performed at 4°C). Each dialysate was subsequently
centrifuged at 11,000 x g for 20 min and the supernatants processed as described below.
For HucR-R118A purification, the supernatant was loaded onto CM-Cellulose and
DEAE-Sepharose columns linked in tandem and equilibrated with HA buffer, pH 7.5. The
HucR-R118A-containing flow-through and wash fractions were dialysed against HAP buffer, pH
6.0 (same as HA buffer, except that 20 mM potassium phosphate (pH 6.0) replaces Tris-HCl)
and loaded onto a CM-Cellulose column equilibrated with HAP buffer, pH 6.0. The HucR-
R118A-containing flow-through was loaded onto a hydroxyapatite column equilibrated with
HAP buffer, pH 6.0 The HucR-R118A-containing flow-through and wash fractions were loaded
onto a heparin column equilibrated with HAP buffer, pH 6.0. HucR-R118A was eluted with a
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linear gradient of 50 mM to 1 M KCl in HAP buffer, pH 6.0. Peak fractions were pooled,
dialyzed against HAP buffer, pH 6.0, and loaded onto a Cibacron Blue 3GA column equilibrated
with HAP buffer, pH 6.0. The column was eluted with a linear gradient of 50 mM to 1 M KCl
and peak fractions pooled. HucR-R118A was concentrated, and the KCl concentration reduced to
∼50 mM, using a Centriprep centrifugal filter device. The glycerol concentration was
subsequently increased to 20%.
For HucR-S104A purification, the supernatant was loaded onto a CM-Cellulose column
equilibrated with HAPT buffer, pH 6.0. The HucR-S104A-containing flow-through and wash
fractions were loaded onto a heparin column equilibrated with HAPT buffer, pH 6.0. The HucR-
S104A-containing wash was loaded onto a Cibacron Blue 3GA column equilibrated with HAPT
buffer, pH 6.0. The column was eluted with a linear gradient of 50 mM to 1 M KCl and peak
fractions pooled. HucR-S104A was concentrated and the KCl concentration reduced to ∼50 mM.
The glycerol concentration was subsequently increased to 20%.
HucR-R118A and HucR-S104A concentrations were determined spectrophotometrically
using ε280 = 13,512 M
-1 cm-1 (calculated from amino acid extinction coefficients) and verified by
SDS-PAGE using bovine serum albumin (BSA) as a standard.
Electrophoretic Mobility Shift Assays (EMSAs)
The DNA used for protein-DNA affinity measurements was prepared by PCR
amplification from the D. radiodurans genome, as described, and spans a 180 bp sequence
containing a single HucR binding site (17). The resulting PCR product, hucO, was gel purified
and 32P-labeled with T4-polynucleotide kinase. EMSAs were performed as described for the wild
type protein; 0.1 nM 32P-labeled hucO was titrated with up to 15 nM of protein dimer (17). Each
binding isotherm was generated by a nonlinear fit of three data sets to the equation: fractional
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saturation of hucO = (n(P)/Kd)/(1 + (P/Kd)), where n represents maximal fractional saturation, P
is the concentration of free protein dimer, and Kd is the apparent equilibrium dissociation
constant. Each Kd is reported as the mean ± S.D. Binding conditions for the competition assays
were as described above, except that a slightly larger, gel purified PCR product of 241 bp was
used (containing a single HucR binding site). Each binding reaction contained 0.1 nM 32P-
labeled hucO titrated with up to 15 nM unlabeled hucO or pGEM5. Protein was added last to the
binding reactions, at a final concentration of 2.5 nM HucR-S104A dimer or 10 nM HucR-R118A
dimer. Protein-hucO binding conditions for HucR-S104A and HucR-R118A, analyzing uric acid
as an effector, were as described previously for wild type HucR, except that protein dimer
concentrations were 3.75 nM and 12.5 nM for HucR-S104A and HucR-R118A, respectively.
Data were fit to an equation for two single-exponential decays:  normalized fractional complex
formation = (n1e
-jL) + (n2e
-kL), where L is uric acid concentration, n1 and n2 are fractional
complex amplitudes, and j and k are decay constants.
Results
Complex Formation is Accompanied by Conformational Changes in Both HucR and hucO
Previous footprinting analyses of the binding interaction between HucR and its sequence-
specific dsDNA binding site suggested that the process involved deformation of the DNA (17).
To assess the role of conformational changes in the DNA double helix in the HucR binding
mechanism, we used CD spectroscopy to analyze HucR-mediated changes in the secondary
structure of a 31 bp DNA fragment (hucO-31) containing the 21 bp HucR binding site. Protein
contributions to the CD signal in the near UV are minimal; above 240 nm, ellipticity is
dominated by contributions from the purine and pyrimidine bases of the DNA duplex. The CD
spectrum of hucO-31 is characteristic of B-form DNA (Fig. 3.1a). Under stoichiometric binding
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Fig. 3.1.  Binding-induced conformational changes in DNA and protein. (a) Near-UV CD
spectra of 2 µM hucO in the absence of protein (closed circles) or in complex with 4 µM HucR
(open triangles). Data were corrected for protein and solvent contributions to the signal.
HucR:hucO-31 complex formation was verified by an electrophoretic mobility shift assay (data
not shown). (b) DNA induced changes in the intrinsic fluorescence spectrum of HucR. The
intrinsic fluorescence spectrum of 1.52 µM HucR was measured in the absence or presence of
increasing concentrations of hucO-31: 0:1 molar ratio of hucO-31 to HucR (black, closed circle);
0.25:1 (red, closed square); 0.5:1 (green, diamond); 0.75:1 (blue, triangle); 1:1 (orange, inverted
triangle).
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conditions, HucR induced a significant increase in the magnitude of the positive CD band at 275
nm. Changes in the ellipticity band at 275 nm have been correlated with changes in the DNA
winding angle (21-24). The HucR mediated effect on the hucO-31 CD band at 275 nm is
consistent with an increase in the number of base pairs per turn of the DNA, or a decrease in the
helical twist of the DNA duplex.
Secondary structure prediction algorithms suggest that the HucR monomer is composed
of 7 α-helices and two β-strands (25, 26) with helices 4 and 5 comprising the two α-helices of
the helix-turn-helix motif. HucR contains two tryptophans located at positions 20 and 72 in the
primary amino acid sequence, and two tyrosines at positions 62 and 79. Secondary structure
prediction places W20 in helix 1, Y62 in helix 2, and W72 and Y79 in helix 3. Structural
modeling of HucR,  and structural analysis of the homologs MexR and MarR, places helix 3 in
the globular interior of the monomer and helices 1 and 2 at the dimer interface (Fig. 3.2). None
of these residues are expected to be in the wing or DNA recognition helix and hence changes in
the intrinsic fluorescence spectrum of HucR would indicate conformational changes in the
dimerization domains and hydrophobic cores of the homodimer. Using an excitation wavelength
of 280 nm, the measured emission signal is dominated by the tryptophan residues due this amino
acid’s much higher quantum yield relative to tyrosine. The intrinsic fluorescence of HucR was
measured as a function of hucO-31 concentration to monitor protein conformational changes
upon complex formation (Fig. 3.1b). The intrinsic fluorescence spectrum of HucR is
characterized by an emission maximum at 338 nm and a “shoulder” at 328 nm. Titration of
HucR with hucO resulted in a significant quenching of the entire fluorescence spectrum, with no
change in the wavelength of maximal fluorescence or in the relative intensity of the shoulder.
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Fig. 3.2.  Model of HucR monomer. The known structure of the closely related MarR family
member, MexR, was used as a template to model HucR via SWISS-MODEL. Residues 178-181




This quenching effect was saturated at a hucO-HucR-monomer molar ratio of 0.5:1, consistent
with previous work demonstrating that HucR binds its cognate DNA site as a homodimer.
The equilibrium sedimentation profile of HucR was attained to determine the oligomeric
state of HucR in the absence of DNA (Figure 3.3). Data were best fit to a model describing a
single, non-associating protein species, yielding a molecular weight average of 43,016 ± 4,374
for HucR. As the calculated molecular weight of a HucR monomer from its primary amino acid
sequence is 19,711.56, the equilibrium sedimentation data suggests that HucR exists
predominantly as a homodimer in the absence of DNA, consistent with crystallographic and
biochemical data for other MarR homologs (12, 19). This supports the accuracy of the Kd value
of 0.29 nM that we reported for the HucR dimer-hucO association, as the binding mechanism is
uncomplicated by monomer-dimer equilibrium.
Uric Acid-HucR Interactions
Uric acid was shown to be an efficient negative effector of HucR’s capacity to bind its
cognate DNA, with a concentration of 0.26 mM being required to reduce HucR-DNA complex
formation to 50%, compared to 5.2 mM for salicylic acid, and 46 mM for acetylsalicylic acid
(17). To monitor binding of HucR to its ligands, we measured the intrinsic fluorescence of HucR
as a function of ligand concentration. Absorption limitations at the excitation wavelength of 280
nm determined the maximum concentration of ligand for which fluorescence intensities could be
fully corrected for inner filter effects. At concentrations up to 50 µM, uric acid induced a strong
quenching effect on the emission spectra of HucR. The quenching of the fluorescence emission
maximum at 338 nm as a function of uric acid concentration was fit to the Hill equation, yielding
an apparent dissociation constant for HucR-uric acid interaction of 11.62 ± 3.71 µM (Fig. 3.4a).
The fit provided a Hill coefficient (nH) of 0.73 ± 0.08, suggesting negative cooperativity.
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Fig. 3.3.  Equilibrium sedimentation profile of HucR. The absorbance of 40 µM HucR
(monomer equivalents) is shown as a function of the radial cell position (lower panel). Data were
fit to a model describing a single, non-associating, species. Residuals to the fit were randomly
distributed (upper panel).
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Fig. 3.4.  HucR-ligand interactions, at low ligand concentrations. (a) Quenching of HucR
fluorescence at 338 nm is plotted against ligand concentration: uric acid (closed circles, solid
line); salicylic acid (closed squares, dashed line); acetylsalicylic acid (closed triangles, dotted
line). (b) Scatchard plot: quenching (338 nm)/uric acid concentration is plotted against
quenching (338 nm). Double-reciprocal plot (inset).
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Analysis of the data using equations for non-equivalent, non-interacting sites resulted in fits with
high error, suggesting that measurements of fluorescence quenching at uric acid concentrations
below 50 µM predominantly monitors binding at higher affinity binding site(s), and that the
observed negative cooperativity is either between equivalent sites in a protein homodimer, or
between the higher affinity site and one, or more, lower affinity ligand binding sites within the
same monomer. Confirmation of negative cooperativity is provided by linear transforms of the
data (Fig. 3.4b). As described by Hensley, Scatchard and double-reciprocal representations of
data provide a diagnostic method for qualitative confirmation of cooperativity (27). A Scatchard
plot of uric acid-induced quenching of HucR fluorescence at 338 nm reveals a clear deviation
from linearity, and the direction of the curvature is indicative of negative cooperativity. The
double-reciprocal plot is hyperbolic, also indicating negative cooperativity (Fig. 3.4b) (27, 28).
Separate titrations of HucR with salicylic acid and acetylsalicylic acid up to final concentrations
of 100 µM resulted in essentially no effect on the intrinsic fluorescence of HucR (Fig. 3.4a),
consistent with previous data showing little effect on DNA-HucR complex formation at these
compound concentrations (17).
To monitor the effects of higher ligand concentrations on HucR fluorescence, the
emission spectra were corrected for inner filter effects of ligand absorbance at emission
wavelengths, and absorbance at the excitation wavelength was removed by normalizing the
emission spectrum to the maximal fluorescence intensity. In this way, alterations to the HucR
emission spectrum could be observed, in addition to the fluorescence quenching observed at low
uric acid concentrations. Titration of HucR with uric acid resulted in a gradual red-shift in the
wavelength of maximal fluorescence, from 338 nm for unbound HucR to 341 nm at 200 µM uric
acid (Fig. 3.5a). This red-shift saturated at 200 µM uric acid, as the fluorescence maximum
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Fig. 3.5.  HucR fluorescence spectra, normalized to the fluorescence intensity maximum. (a)
HucR + uric acid; (b) HucR + salicylic acid; (c) HucR + acetylsalicylic acid. Representative
spectra from one of two separate experiments, showing HucR in the absence of ligand (black,
closed circle) or in the presence of 30 µM ligand (red, closed square), 200 µM ligand (blue,
closed diamond), and 1 mM ligand (green, closed triangle). The divergence of the spectrum of
HucR + 1mM salicylic acid from the other spectra in panel (b) is likely due to difficulties in
correcting for the inherent fluorescence of salicylic acid (wavelength of maximum fluorescence
∼410 nm).
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remained at 341 nm at uric acid concentrations up to 1 mM. The fluorescence shoulder,
characteristic of the HucR spectrum, is sensitive to uric acid concentration. The shoulder
intensity, relative to the fluorescence maximum, underwent a gradual quenching with increasing
uric acid concentration. These effects on the HucR emission spectrum were not induced by the
low affinity ligands, salicylic acid and acetylsalicylic acid (Fig. 3.5b and 3.5c). In comparison to
the red-shift observed with uric acid, separate titrations up to 1 mM of each compound did not
shift the wavelength of maximum fluorescence from 338 nm. In addition, neither salicylic acid
nor acetylsalicylic acid induced quenching of the fluorescence shoulder. From this data, we
conclude that three characteristic alterations to the fluorescence spectrum of HucR are indicative
of uric acid binding: (1) quenching, observable at low ligand concentrations, (2) red-shift in the
wavelength of maximum fluorescence intensity, and (3) quenching of the intensity of the
shoulder at an emission wavelength 10 nm below the wavelength of maximum intensity.
HucR Mutants
The observation of negative cooperativity in uric acid binding to HucR (Fig. 3.4) is
consistent with three possible models: (1) there are at least two separate uric acid binding sites
per HucR monomer and the negative cooperativity exists between these sites, (2) there is only
one uric acid binding site per HucR monomer and the negative cooperativity is between
homologous sites in a homodimeric assembly, or (3) there are multiple uric acid binding sites per
monomer and the negative cooperativity is between homologous sites in a homodimer. The co-
crystal structure of MarR with salicylate reveals two binding pockets for salicylate within each
half of a homodimer, designated as sites SAL-A and SAL-B (12). However, the physiological
relevance of these binding pockets remains to be determined, as the protein crystals were
saturated at the exceedingly high salicylate concentration of 250 mM.
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Primary sequence alignment of HucR with its most closely related homologs from the
MarR family revealed a high degree of conservation of residues that form the ligand binding
pockets of MarR (12, 17).  Most striking in the alignment is the conservation of residues that
form ligand binding pocket SAL-A in MarR. The guanidinium group of R118 (numbering
according to HucR primary sequence) forms a hydrogen bond with the carboxylate group of
salicylate at this site (∼3 Å); R118 is strictly conserved in the alignment. The threonine residue
that hydrogen bonds to the hydroxyl group of salicylate in site SAL-A (∼3 Å) is strictly
conserved amongst the HucR homologs in the alignment, but is replaced by a homologous serine
in HucR (S104). The hydrogen bonding residues in site SAL-B are less well conserved in the
alignment, but HucR retains R109 which coordinates with the carboxylate of salicylate
To determine whether or not the mechanism of ligand recognition suggested by the MarR
co-crystal structure is retained by HucR, we generated two HucR mutants, each containing a
single amino acid substitution in ligand binding site SAL-A. HucR-R118A and HucR-S104A
were overexpressed and purified to greater than 95% homogeneity, as shown by SDS-PAGE
(Fig. 3.6). Secondary structure prediction, sequence alignment against MarR, and structural
modeling of HucR (Fig. 3.2) positions R118 in the β-hairpin motif that forms the characteristic
“wing” structure of winged helix proteins and positions S104 in the fifth alpha-helix of HucR
that forms the DNA recognition helix of the winged helix motif. Therefore, changes in both the
ligand- and DNA-binding properties of HucR were expected from each mutation.
DNA Binding Properties of HucR Mutants
We measured the affinities of HucR-R118A and HucR-S104A for the HucR binding site,
hucO. EMSA revealed an apparent Kd of 0.23 ± 0.03 nM (∆Gassoc = -13.0 kcal/mol) for the
interaction of HucR-S104A with hucO, nearly identical to the apparent Kd of 0.29 ± 0.02 nM
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Fig. 3.6. Purified HucR mutants. Lane 1, molecular mass marker in kDa; lane 2, 1 µg of








previously measured for wild type HucR under identical conditions (Fig. 3.7). The affinity of
HucR-R118A for hucO was reduced approximately five-fold, revealing an apparent Kd of 1.60 ±
0.14 nM (∆Gassoc = -11.9 kcal/mol). The complex of each HucR mutant with hucO dissociates
during electrophoresis, as reflected in a fractional saturation less than 100%. In addition, whereas
only a single protein-DNA complex is observed in each HucR and HucR-R118A titration, a
second complex may be distinguished at high HucR-S104A concentrations.
The protein-DNA complex instability observed for both HucR-S104A and HucR-R118A
suggested the possibility that the DNA binding specificities of the HucR mutants were reduced,
relative to the wild type. A measure of the sequence specificity in binding by HucR-S104A and
HucR-R118A was obtained by a direct comparison of the abilities of unlabeled hucO and
pGEM5 to compete for protein binding with 0.1 nM 32P-labeled hucO (Fig. 3.8). Each HucR
mutant is highly sequence specific in its DNA binding capacity, as reported for the wild type
protein. Titration of unlabeled hucO to a concentration of 5 nM elicited a clear reduction in
labeled complex formation with HucR-S104A and HucR-R118A  However, when using pGEM5
as a competitor, only a slight reduction in the labeled hucO-protein complex is observed at a
concentration of 15 nM pGEM5, for each mutant. Since pGEM5 contributes a greater than
twelve-fold molar excess of base pairs compared to hucO, the competition assays demonstrate
the retention of a definite sequence specific binding preference for both HucR mutants.
Consistent with the apparent DNA binding constants for the HucR variants (Fig. 3.7), the
DNA-responsive intrinsic fluorescence spectra of the proteins suggest altered mechanisms of
DNA association (Fig. 3.9). A comparison of the intrinsic fluorescence spectra of HucR, HucR-
S104A, and HucR-R118A reveals significant differences. Whereas the measured fluorescence
maximum is at 338 nm for each protein, the peak intensity is 86.2 for HucR, 73.2 for HucR-
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Fig. 3.7. Affinity measurements of HucR mutants for the HucR binding sequence (hucO).
Panels a-c depict EMSAs in which 0.1 nM hucO was titrated with protein. Uncomplexed hucO
and protein-DNA complexes are identified by arrows. (a) Wild type HucR: 0, 0.05, 0.125, 0.25,
0.5, 1.0, 2.5, 5.0, 15.0 nM (b) HucR-S104A; protein concentrations as for panel a (c) HucR-
R118A: 0, 0.25, 0.5, 2.5, 5.0, 10.0, 15.0, 20.0 nM (d) Binding isotherms for HucR-S104A (solid
line, closed circles) and HucR-R118A (dashed line, closed squares). Data were collected in
triplicate. Fractional saturation is reported as the mean ± S.D.
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Fig. 3.8. Competition assays. Binding reactions involved 0.1 nM 32P-labeled hucO and titration
of up to 15 nM unlabeled hucO or pGEM5, followed by the addition of protein. Complexes were
resolved by EMSAs. The first lane in each gel contains only labeled DNA. Concentrations of
unlabeled competitor DNA are indicated above the corresponding lanes. Complexed and
uncomplexed hucO are identified by arrows. (a) HucR-S104A (b) HucR-R118A.
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Fig. 3.9.  Fluorescence spectra of free and DNA-bound HucR-variants. The intrinsic
fluorescence spectrum is shown for 1.52 µM of each HucR variant before (solid line, closed
circles) or after (dashed line, open triangles) incubation with 0.76 µM hucO-31. (a) Wild type
HucR. (b) HucR-S104A. (c) HucR-R118A.
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S104A, and 111.6 for HucR-R118A, suggesting that the environments of either one, or both, of
the tryptophans differ in these HucR variants. When complexed with a stoichiometric quantity of
hucO, such that all protein is expected to be in complex with DNA, fluorescence quenching is
observed for each protein, indicating altered environments for one, or both, tryptophans.
However, the degree of quenching induced by complex formation differs significantly between
the proteins. HucR interaction with its cognate DNA binding site leads to a quenching of
intrinsic fluorescence by 10.0%, compared to 5.4% for HucR-S104A, and 22.2% for HucR-
R118A. From these two observations, we conclude that protein conformational changes upon
DNA binding by of HucR, HucR-S104A, and HucR-R118A also differ.
Uric Acid Binding by HucR Mutants
As both R118 and S104 mediate hydrogen bond contacts with a ligand in the crystal
structure of MarR, and as both of these residues are highly conserved in the MarR family, we
also analyzed the roles  of each of these side chains in uric acid recognition by HucR. For each
HucR mutant, increasing concentrations of uric acid reduced protein-hucO complex formation
(Fig. 3.10a,b). However, in contrast to the case of wild type HucR, where DNA complex
formation was abolished in the presence of approximately 1 mM uric acid, we observed faint
smears extending above the band of free hucO at uric acid concentrations up to 10 mM. This
effect was shown not to be a result of uric acid or its solvent affecting the DNA migration (data
not shown). Additional controls confirmed that the uric acid solvent did not affect protein-hucO
complex formation (data not shown). We therefore interpreted the smearing above the band of
free DNA to be residual DNA complex formation with HucR-S104A and HucR-R118A. At uric
acid concentrations below 1 mM, a steep decrease in normalized DNA complex formation is
seen for all three variants (Fig. 3.10c). At uric acid concentrations above 1 mM, the antagonistic
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Fig. 3.10.  DNA-binding antagonism by uric acid. Protein-hucO association was challenged
with increasing concentrations of uric acid, and complexes resolved by EMSA. Reactions
contained 0.1 nM 32P-hucO. Uric acid concentrations are 0, 0.1, 0.5, 1, 5, 10 mM (a) HucR-
S104A. (b) HucR-R118A. (c) normalized protein-hucO complex formation as a function of uric
acid concentration for wild type HucR (solid line, closed circles), HucR-R118A (dashed line,
closed squares), and HucR-S104A (dotted line, closed triangles). Experiments were performed in
triplicate and data reported as mean ± standard error.
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effect of uric acid approaches saturation; for wild type HucR, fractional complex saturation
approaches zero while fractional saturation for the HucR-mutants near saturation at ∼30%. At 10
mM uric acid, approximately 20% of the HucR-S104A complex remains and approximately 10%
of the HucR-R118A complex remains.
In addition to affects on DNA affinity, the S104A and R118A amino acid substitutions in
HucR, therefore, each appear to reduce the protein’s response to high concentrations of uric acid.
This data is consistent with there being at least two separate uric acid binding sites in HucR with
dissimilar ligand affinities. Our data suggests that the mutations at HucR positions 104 and 118,
corresponding to ligand binding pocket SAL-A in MarR, each affect a lower affinity uric acid
binding site.
The interaction of uric acid with HucR-S104A and HucR-R118A was measured by
intrinsic fluorescence (Fig. 3.11a). For HucR-S104A, the apparent Kd for interaction with uric
acid was 7.4 ± 0.5 µM, compared to 9.7 ± 3.2 µM for HucR-R118A, and 11.6 ± 3.7 µM for
HucR. Interestingly, the negative cooperativity in uric acid binding by HucR was reduced, or
lost, through the S104A and R118A mutations. Whereas HucR displayed an nH of 0.73 ±0.08,
fits for HucR-S104A and HucR-R118A revealed nH values of 1.10 ± 0.06 and 0.94 ± 0.16,
respectively. As for the wild type protein, fits of the data for the mutants to an equation for non-
equivalent, independent sites resulted in high error. As measurements of fluorescence quenching
at low concentrations of uric acid predominantly monitors binding at a high affinity site(s), the
unchanged, or small increase in, affinity for uric acid observed for both HucR mutants is
consistent with each mutation residing in a low affinity uric acid binding site.
We then compared the effects of uric acid on the normalized fluorescence spectra of
HucR, HucR-S014A, and HucR-R118A. The uric acid induced red-shift in the wavelength of
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Fig. 3.11.  Fluorescence detection of uric acid binding to HucR-mutants. (a) Binding
isotherms for protein-uric acid interactions. Quenching of protein fluorescence at 338 nm is
plotted against uric acid concentration for wild type HucR (solid line, closed circles), HucR-
R118A (dashed line, closed squares), and HucR-S104A (dotted line, closed triangles). (b and c)
Fluorescence spectra, normalized to the fluorescence intensity maximum, for protein in the
absence (black, closed circles) or presence of 30 µM (red, closed squares), 200 µM (blue, closed
diamond), and 1 mM (green, closed triangles) uric acid. (b) HucR-S104A. (c) HucR-R118A.
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maximal fluorescence intensity for HucR was also observed in both HucR mutants (Fig.
3.11b,c). For each protein, the wavelength of maximal intensity shifted from 338 nm, for the
apo-protein, to 341 nm at 200 µM uric acid and remained at 341 nm at a ligand concentration of
1 mM.  The reduction of the shoulder fluorescence intensity relative to the peak intensity
observed in HucR, was also retained in both HucR mutants, even at low uric acid concentrations.
We therefore concluded that these effects on the fluorescence spectra were induced by ligand
binding at a site that was unaltered by the separate mutations at S104 and R118. Moreover, as the
red-shift and shoulder-quenching effects were observed at ligand concentrations below 50 µM,
we conclude that these effects correspond to binding at a high affinity site(s) and that the S104A
and R118A mutations perturb a low-affinity ligand binding site(s).
Discussion
HucR-hucO Association − Conformational Changes
The conformational changes observed in HucR and the DNA upon binding indicates that
the interaction is not a static one. Rather, a DNA distortion is observed that may indicate a
decrease in the duplex winding angle (i.e. an increase in the number of base pairs per turn) (Fig.
3.1). This finding is consistent with the mechanism of site specific DNA binding by the winged
helix protein MerR from E. coli which has been shown to decrease the helical twist of the DNA
duplex, in addition to inducing a 25° bend, upon complex formation (29). Binding to DNA by a
Bacillus subtilis winged helix protein from the MerR family, BmrR (in its activated ligand bound
state), is accommodated by a significant distortion in the cognate DNA binding site, with a
reduction in the helical twist and a bending of the DNA duplex by ∼50° (30). Insertion of the
recognition helix of the E. coli helix-turn-helix protein TetR into the major groove causes a
widening of the major groove by 2.8 Å and a concomitant reduction in the DNA helical twist,
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but does not alter the overall curvature of the DNA binding site (31). Similarly, the
Staphylococcus aureus protein QacR, from the TetR family, does not bend DNA upon binding,
but insertion of the recognition helix into the major groove induces a significant reduction in the
helical twist to 32.1° per bp (and 11.2 bp per turn) and a concomitant widening of the major
groove (32). As the center of each inverted repeat in the HucR binding site is separated by one
full turn of the double helix, it is tempting to speculate that unwinding of the double helix is
required to accommodate insertion of the recognition helices of a HucR homodimer into
consecutive, widened major grooves. In the absence of a crystal structure of a DNA-bound MarR
homolog, this is the first piece of evidence suggesting that untwisting of the DNA duplex and
concomitant widening of the major groove is required to accommodate binding by these proteins.
Our finding of HucR-induced changes to DNA structure is interesting in comparison with
suggestions that MarR-DNA binding is accommodated strictly by protein conformational
changes (33). However, these suggestions were based on observations that MarR-binding to
DNA did not confer sites of hypersensitivity to DNaseI, which does not preclude the possibility
of alterations to the helical twist of the DNA duplex (8, 34). However, it is interesting to note
that DNA binding by the archaeal winged helix protein Sac10a from Sulfolobus acidocaldarius
induces the opposite effect on the DNA duplex; the DNA is distorted such that the number of
base pairs per turn decreases (winding angle increases) (35).
Quenching of the intrinsic fluorescence of HucR upon complex formation with hucO
suggests conformational changes in the homodimer that extend beyond the helix-turn-helix and
wing motifs that are predicted to make all direct contacts with DNA; the two HucR tryptophans
are expected to be in the globular interior of the protein and at the dimer interface (Fig. 3.1b, 2).
Quenching of the intrinsic fluorescence of the indole ring of tryptophan has been associated with
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conformational shifts to three altered environments: (1) increased solvent exposure, (2) closer
contact with amide bonds in the peptide backbone, or (3) closer contact with polar side chains
(36, 37). Additional work will be required to elucidate the nature of the conformational changes
induced in HucR and its cognate DNA binding site upon complex formation.
HucR DNA-Binding Mechanism
Given the predicted locations of S104 and R118 in the DNA recognition helix and wing
of HucR, respectively, it is not surprising that alanine substitutions at these positions affected
HucR-hucO association (Fig. 3.7). The protein-DNA complex stability for each HucR-mutant,
relative to that of the wild type protein, is reduced on the gel; we cannot say if this relative
instability is also present in solution. However, an increased koff for the complex equilibria
suggested from EMSA would explain the increased Kd observed for HucR-R118A, relative to
HucR. Also consistent with the increased apparent Kd for HucR-R118A is the intrinsic
fluorescence data suggesting an altered DNA-binding mechanism for this mutant: the greater
intrinsic fluorescence of HucR-R118A relative to HucR and the proportionally greater extent of
quenching induced by DNA-binding is consistent with an altered protein conformation that must
undergo a different conformational change to accommodate DNA-binding (Fig. 3.9). The
intrinsic fluorescence data also offers an explanation for the nearly identical apparent Kd values
for the S104A and wild type HucR-variants (Fig. 3.9). The combination of the lower intrinsic
fluorescence of HucR-S104A, relative to HucR, and the proportionally lower degree of
quenching induced by DNA-binding suggests that the state of the free protein is closer to the
DNA-binding conformation, perhaps leading to a higher kon for complex formation. The
combined effects of an increased koff, suggested by EMSA, and an increased kon is consistent
with the essentially unaltered apparent Kd for HucR-S104A. In addition, the modest alterations to
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DNA binding affinities observed in our HucR mutants is consistent with mutational analysis of
MarR, in which the selection of trans-dominant mutants that interfered with the activity of wild
type MarR did not isolate individual mutations of the arginine or threonine corresponding to
HucR positions 118 and 104 (18).
These effects, induced by the individual mutations, upon HucR’s site specific DNA-
binding support the prediction that HucR mediates binding via a winged helix fold. In addition,
the decreased affinity for the HucR binding site, elicited by the R118A mutation, strongly
suggests that the β-hairpin wing, and not just the recognition helix, makes direct contacts with
the DNA duplex. Moreover, the high degree of amino acid conservation  in the wing region of
MarR homologs suggests its importance in directing association with DNA (17). It will be
interesting to determine whether the HucR wing motif contacts the minor groove, as seen with
the prokaryotic winged helix proteins MuR and FadR, or with the sugar-phosphate backbone, as
observed with BmrR, or within the major groove, as observed with the eukaryotic protein, RFX1
(30, 38, 39).
HucR-Uric Acid Association and Negative Cooperativity
The apparent Kd of 11.62 ± 3.71 µM  for binding of uric acid to HucR indicates a ligand-
binding affinity significantly higher than has been observed for MarR. The apparent dissociation
constants for MarR binding to the phenolic compounds salicylate, plumbagin, 2,4-dinitrophenol,
and menadione have been measured to be 500 µM, 250 µM, 250 µM, and 800 µM, respectively
(8, 11, 33). However, the HucR-uric acid affinity is similar to the drug binding affinities of the
MarR homolog, EmrR, which binds phenolic ligands with Kd values ranging from approximately
2.0 – 15.0 µM (40). The ligand dissociation constants for the multi-drug binding protein QacR,
range from 0.1 – 5 µM (33).
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Our uric acid binding assays lead us to conclude that the HucR monomer contains at least
two separate uric acid binding sites with dissimilar affinities, and that the HucR site
corresponding to the MarR ligand-binding pocket SAL-A binds uric acid with low affinity.
These conclusions are based upon the following observations: 1) Uric acid-induced quenching of
HucR intrinsic fluorescence reveals negative cooperativity in uric acid binding, indicating that at
least two uric acid binding sites are involved (Fig. 3.4). Uric acid quenching predominantly
monitors binding at a high affinity site(s) as indicated by the poor fit of the data to equations for
multiple, non-equivalent, non-interacting sites, suggesting that negative cooperativity is between
homologous sites in each monomer. 2) The S104A and R118A mutations result in little to no
change in uric acid binding affinity and abolish cooperativity of uric acid binding, consistent
with each mutation residing in the same binding site (Fig. 3.11a). 3) The alterations to the
normalized fluorescence spectra observed at uric acid concentrations up to 1 mM were nearly
identical for all three HucR variants, indicating that these effects were induced by ligand binding
at a site unaltered by the separate S104A and R118A mutations (Fig. 3.5; 3.11b,c). Moreover, as
these alterations to the emission spectra also occurred at uric acid concentrations below 50 µM,
we conclude that these effects correspond to binding at high affinity site(s). 4) Increasing
concentrations of uric acid up to 1 mM result in a similar, steep antagonism of HucR-hucO
complex formation for HucR, HucR-S104A, and HucR-R118A (Fig. 3.10). However, unlike
HucR, residual protein-DNA complex is observed for both HucR mutants up to 10 mM uric acid.
These observations are consistent with each mutation residing in a low affinity ligand binding
site. Saturation of this lower affinity site in wild type HucR nearly completely abolishes complex
formation with DNA at a uric acid concentration of 2 mM, whereas approximately 30% of the
initial protein-DNA complex remains at this ligand concentration for both mutants.
101
The loss of uric-acid binding cooperativity induced by each mutation, combined with the
differences in the intrinsic fluorescence spectra of the HucR variants (Fig. 3.9), suggests that
each mutation propagated a conformational change in HucR that disrupted the cooperativity
between the high affinity site(s) in each half of the homodimer. Alternatively, uric acid binding
at the low affinity site (containing HucR residues S104 and R118) might stabilize the recognition
helix in a position such that ligand binding at the high affinity site might reduce the affinity of
the corresponding site in the adjacent monomer. This latter model is consistent with the expected
ligand-binding site SAL-B in HucR. The data does not rule out the possibility that the negative
cooperativity in HucR is between the low affinity site comprised of residues S104 and R118, and
a separate high affinity site(s). However, ligand binding in the low-affinity, SAL-A site is
unlikely to be involved in negative cooperativity, based on our observation that negative
cooperativity is seen at uric acid concentrations below 50 µM, where site SAL-A is probably not
filled.
It has been proposed that the physiological benefit of negative cooperativity is that it
increases the concentration range over which the protein can respond (36, 41). In addition,
negative cooperativity can increase the protein’s sensitivity to low ligand concentrations. Given
the tendency of uric acid to precipitate and the consequential deleterious effects to the cell, it
would likely be advantageous for D. radiodurans to upregulate uricase in response to low uric
acid concentrations.
Possible Basis for Changes in the Fluorescence Spectrum of HucR on Ligand or DNA Binding
W20 of  HucR is predicted to reside in an N-terminal α-helix that does not exist in either
MarR or MexR. As the N-terminal helices of both MarR and MexR form their respective
hydrophobic dimer interfaces, it is likely that the extra N-terminal helix of HucR serves in such a
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capacity. It is likely that this helix is quite flexible in the uric acid-mediated allosteric mechanism
that regulates DNA binding of HucR. Structural determination of MarR was based upon a single
homodimer in the asymmetric unit (12). The DNA binding domains of the ligand-bound
structure were in a conformation that precluded DNA binding to the known, palindromic binding
site (8, 12). Movement of the DNA binding domains to accommodate binding to the sequence-
specific sites would require significant distortion of MarR α-helix 1 and the C-terminal α-
helices. Structural determination of MexR allowed for multiple views of this protein, as the
asymmetric unit was comprised of 4 separate MexR homodimers. There is significant flexibility
in the MexR dimerization domain, as observed in a 17° deviation in the helix orientation of α-
helix 1, and a 4.9 Å shift in its helix midpoint position. Moreover, as dimerization of both MexR
and MarR are mediated primarily by van der Waals contacts involving their respective N- and C-
terminal helices, flexibility in this domain is expected as such hydrophobic interactions do not
require specific molecular orientations. Except for the “wing” itself, the MexR winged-helix
DNA binding domain appears to be considerably less flexible; rather, each domain moves as a
rigid body relative to the homologous domain in the dimer. HucR α-helix 3, which contains
W72,  corresponds to the first helix in this motif. The alterations of the HucR fluorescence
spectrum observed upon DNA binding and ligand binding are therefore consistent with
conformational changes in the dimerization domain containing HucR tryptophan 20 and/or rigid
movements of HucR helix 3 in the winged-helix DNA binding domain.
Proposed Mechanism for Uric Acid-Mediated Allosteric Control of HucR-DNA Complex
Formation
Though there is considerable variability in the mechanisms of allosteric control of the
DNA-binding properties of homodimeric winged helix proteins, the effector binding domains in
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these proteins are generally distal to the winged helix DNA binding domains, and ligand-induced
conformational changes are propagated to the winged helix motif (39). Such domain separation
is observed in MerR and other MerR family members including BmrR and MtaN as well as in
FadR from the GntR winged helix family (33). For the CRP protein, signals are transmitted from
the N-terminal cAMP-binding domain to the C-terminal DNA-binding domain (42). Likewise,
the phosphorylated “receiver” domain of OmpR is separated by a linker region from its winged
helix DNA-binding domain (43). Indeed, all characterized prokaryotic multidrug binding
transcriptional regulators other than MarR incorporate a spatial separation of ligand- and DNA-
binding domains (33, 44). Even though the MarR family is proposed to share a common
evolutionary history with the GntR, MerR, and Crp families, MarR proteins appear to have an
interesting structural organization such that the ligand- and winged helix DNA-binding domains
almost completely overlap in the residues involved.
The MexR structure reveals an “open” dimer conformation in which basic charge
repulsions between the two DNA binding domains maintains the dimer in a conformation that
can be docked onto the known MexR DNA binding site.  Comparison to another MexR dimer
suggested a mechanism of allosteric control in which the binding of a potential effector between
the two DNA binding domains perturbs the relative orientation of the monomers to become
incompatible with DNA binding. The mechanism involves effector-mediated neutralization of
the charge repulsion between the DNA binding domains and hydrophobic interactions between
the effector and protein side chains, with the result that the distance between the DNA binding
domains is reduced to be no longer optimal for DNA binding. Support for this mechanism comes
from the MarR-salicylate co-crystal structure, which reveals the orientation of the DNA-binding
lobes to be incompatible with binding to the MarR binding sites. Indeed, the DNA-binding
104
capacities of a number of homodimeric winged helix proteins are mediated by allosteric changes
in the proximal distance between relatively rigid DNA binding lobes (39). In the multidrug-
binding protein QacR, ligand binding induces a coil-to-helix transition that propagates a protein
conformational change resulting in a 36.7 ° rotation and 9.1 Å translation of the DNA-binding
domain; the altered distance between the recognition helices of the homodimer precludes binding
to its DNA site (44)
As for MexR, MarR, and other winged-helix proteins, HucR is strongly electropositive in
its proposed DNA binding region. Uric acid could serve to neutralize charge repulsions that
maintain the DNA binding lobes of the HucR dimer in a DNA binding conformation. Uric acid’s
hydrophobic rings could also potentiate van der Waals interactions with hydrophobic HucR side
chains, further distorting the relative conformations of the monomers. It is likely that the uric
acid binding site mediating such conformational events corresponds to ligand binding site SAL-
B in MarR. Ligand binding site SAL-A is located between the DNA recognition helix and the
wing region, whereas site SAL-B is located on the other side of the DNA recognition helix; the
two SAL-B sites in the homodimer would be adjacently positioned in the channel between the
DNA binding lobes (6 Å wide in MarR structure). Binding of uric acid at such a position could
potentially disrupt the relative orientation of the HucR DNA binding domains. Such a
perturbation of the spatial separation of the recognition helices in the homodimer would be
dependent upon the flexibility of the dimerization domain suggested by the fluorescence data.
Support for our observation that site SAL-A in HucR is a low affinity ligand binding site and our
hypothesis that site SAL-B mediates allosteric events comes from the fact that the residues that
comprise ligand binding site SAL-A, but not SAL-B, are highly conserved in MexR and MexR
does not respond to salicylic acid as an effector (19). The conservation of residues in the
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proposed site SAL-B in HucR, relative to site SAL-B in MarR, is greater than for MexR. The
observed differences may explain the high affinity of HucR for uric acid.
The significant alterations in the fluorescence spectrum of HucR that are induced upon
uric acid and DNA binding likely correspond to movements of both tryptophans (though we
know not to which degree each contributes). According to this hypothesis, uric acid would distort
the relative positions of the DNA binding domains in the homodimer, thus altering the
environment of tryptophan 72. Such movements of the winged-helix domains would require
flexibility of the N-terminal α-helices of each monomer, altering the environment of HucR
tryptophan 20. Similarly linked movements would be expected for the HucR dimer to adopt a
DNA binding conformation.
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Interest in the MarR family of transcriptional regulators has increased since the eponym,
MarR from E. coli, was identified as a repressor of a chromosomally encoded operon that
confers intrinsic resistance to structurally diverse drugs, organic solvents, and oxidative stress
agents (1-4). Gene regulatory activity by MarR homologs is mediated by DNA-binding via a
conserved winged helix motif that likely originated before the divergence of archaea and bacteria
∼3.5 billion years ago (5, 6). MarR proteins appear to be especially well adapted to binding
anionic lipophilic compounds, particularly aromatic ligands, and this may prove to be a defining
feature of all members of this family. The identification of two putative MarR homologs in the
D. radiodurans genome, dr1159 from chromosome I and dra0248 from chromosome II,
suggested the presence of novel phenolic-sensitive regulatory systems in this eubacterium.
Particularly enticing, given the extreme resistance of D. radiodurans to radiation, desiccation,
and oxidative stresses, is the involvement of numerous MarR homologs in stress response
systems.
DNA-Binding by HucR
The high affinity of HucR for its cognate DNA-binding sequence (hucO) (Kd = 0.29 ± 0.02
nM) (Fig. 2.5) is comparable to the binding affinities of ExpG (Kd = 0.58-1.3 nM) and MarR (Kd
∼1 nM) for their respective sites (7, 8). The homolog PecS, however, binds site-specifically with
apparent Kd’s ranging from 5 nM to ∼200 nM (9, 10). Despite the dearth of quantitative DNA-
binding characterization for MarR proteins, it is clear that these proteins bind site-specifically to
palindromic, or pseudopalindromic, sequences, consistent with the fact that most prokaryotic
transcription factors bind DNA as homodimeric assemblies. HucR binds hucO as a dimer (Fig.
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2.5D and Fig. 3.1) and exists as a dimer in solution (Fig. 3.3) consistent with other evidence that
MarR proteins are predominantly dimers in the absence of DNA (7, 8, 11, 12).
Sequence alignment of HucR with its most closely related homologs indicates high
conservation of residues in the predicted β-hairpin (wing) motif in the DNA-binding domain,
suggesting the importance of this structure in gene regulatory activity (Fig. 2.2). Binding site
sizes for most characterized MarR homologs range from 21 bp (for HucR) (Fig. 2.6) to 29 bp
(for MexR), similar to the regions of DNaseI protection observed for most dimeric, canonical
HTH proteins (13-15). However, biophysical, genetic, and structural data clearly implicates the
involvement of the wing motif in mediating DNA contacts in most winged helix proteins (16-
18). Accordingly, the substitution of an arginine with an alanine in the wing motif of HucR
(HucR-R118A) decreased the binding affinity for hucO ∼5-fold (Fig. 3.7). Moreover, HucR-
S104A and HucR-R118A demonstrated reduced DNA-complex stability on the gel, but not
reduced sequence-specificity (Fig. 3.7 and 3.8). It is likely that the reduced complex stabilities
observed on the gel are a consequence of the amino acid substitutions inducing global
conformational changes propagated throughout the protein, as suggested by the altered intrinsic
fluorescence spectra of the HucR variants (Fig. 3.9). Thus, the high affinity and stability of the
HucR-hucO  complex appears to depend not only on specific sequence and structural
relationships in the winged helix domain, but also on the conformations of the residues that
comprise the dimerization domain. Atomic force microscopy data suggests that DNA bending is
critical in the binding mechanism of the MarR homolog, ExpG (7). We provide the first evidence
that alterations to the helical twist of the DNA duplex may also be part of the DNA-binding
mechanisms of MarR homologs (Fig. 3.1).
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Negative Cooperativity in Uric Acid Binding
Interestingly, the MarR-salicylate co-crystal structure identified residues from the winged
helix DNA-binding domain mediating all of the H-bond and hydrophobic contacts with the two
salicylate molecules bound at sites SAL-A and SAL-B (19). This co-localization of ligand- and
DNA-binding domains is unusual in transcriptional regulators, and the physiological relevance of
the MarR structural data is questionable, as the protein crystals had been soaked in a relatively
concentrated solution of salicylate. Nevertheless, residues comprising both sites are conserved in
the MarR family, particularly in site SAL-A (Fig. 2.2) (19). Whether such conservation is related
to the importance of these residues in ligand- and/or DNA-binding had not been rigorously
analyzed.
Our results indicate that in HucR, site SAL-A is a weak uric acid binding site and that a high
affinity uric acid binding site(s) exist elsewhere in this protein (Fig. 3.4 and 3.11). This notion is
supported by observations that mutations at site SAL-A resulted in only modest alterations to
uric acid-responsive HucR-hucO complex formation at low uric acid concentrations, but allowed
residual protein-DNA complex at uric acid concentrations that eliminated wild type complex
(Fig. 3.10). It is likely that site SAL-B is a high affinity ligand binding site, and the relatively
reduced conservation of residues at this site might be the consequence of adaptation to structural
variation of the phenolic ligands. To address this hypothesis, efforts are underway to purify a
HucR variant with an arginine to asparagine substitution at position 106, corresponding to M74
in MarR site SAL-B. Additional efforts are underway to generate a HucR variant with an
arginine to asparagine substitution at position 109, corresponding to R77 in MarR site SAL-B.
Our data suggesting a high affinity ligand binding site, possibly corresponding to site
SAL-B, in conjunction with our observations of intrinsic flexibility in HucR (Fig. 3.1 and 3.5)
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supports a model of ligand-responsive allosteric control similar to the one proposed by Lim (11).
Uric acid binding at a high affinity site could alter the relative orientations of the DNA-binding
lobes of the HucR dimer such that DNA-binding is no longer accommodated. Our data indicating
that HucR mutations at positions 118 and 104 attenuate, or remove, the negative cooperativity in
uric acid binding, in concert with the fluorescence data suggesting altered intrinsic
conformations for the HucR variants, is consistent with uric acid binding with negative
cooperativity at a high affinity site in each monomer (Fig. 3.9 and 3.11). Ongoing efforts by Tee
Bordelon in the lab of Dr. Marcia Newcomer to obtain a high-resolution crystal structure of
HucR will likely enhance our understanding of the allosteric mechanism by which uric acid
modulates DNA-binding activity of HucR.
Physiological Considerations
HucR is a uric acid-responsive autoregulator and regulator of the expression of a putative
uricase enzyme (Fig. 2.7 and 2.8). Uricase converts uric acid to allantoin in the purine
degradation pathway in both prokaryotes and eukaryotes. The genetics of purine catabolic
pathways have been delineated in relatively few prokaryotic species, including Bacillus subtilis
and Methanococcus vannielii, but indicate that they are diverse, and include both aerobic and
anaerobic systems (20-22). However, catabolism beyond uric acid occurs only in the aerobic
pathways, as O2 is a required electron acceptor in uricase activity (22). It is worth noting that D.
radiodurans genes dr1160  and dr1161 encoding the putative uricase and a predicted,
transthyretin-like protein share significant homology to the genes pucL and pucM from B.
subtilis, respectively, which have been shown to encode uricase activity (21). Moreover, uricase
activity was detected in total protein extracts from D. radiodurans (Fig. 2.8), and we are in the
process of cloning the HucR-regulated gene encoding this putative uricase to confirm that it is a
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functional enzyme. It is likely that D. radiodurans possesses a full complement of genes for
purine catabolism, as a genome search identifies the following putative enzymes of aerobic
purine catabolism: adenine deaminase (dra0270), xanthine dehydrogenase (N-terminal subunit,
dra0177; C-terminal subunit, dra0178), allantoinase (dr1153), and N-carbamyl-L-amino acid
amidohydrolase (dr1154).
Upregulation of uricase activity in response to increased concentrations of its substrate,
uric acid, is logical given the low solubility of this compound. However, given the ability of uric
acid to scavenge damaging reactive oxygen species (23, 24), it seems beneficial to the cell for
this uric acid-modulated response to be attenuated, such that an optimal concentration of uric
acid is maintained in the cell below a critical threshold where precipitation would occur. Though
it remains to be determined how many uric acid binding sites must be filled in the HucR dimer to
inhibit HucR-hucO complex formation, the negative cooperativity observed in uric acid binding
in HucR could be critical in maintaining optimal uric acid levels in the cell. Negative
cooperativity could extend the uric acid concentration range over which HucR can respond, by
effectively increasing the uric acid concentration at which all HucR-mediated uricase repression
is relieved, thus allowing a basal level of uric acid to remain in the cell. Simultaneously, negative
cooperativity of uric acid binding would effectively decrease hucR transcription at low uric acid
concentrations, likely to maintain an optimal level of uricase in the cell. RNA dot blot analysis
suggests that hucR and dr1160 transcript levels are proportionally upregulated in response to uric
acid (Fig. 2.8), but a full understanding of this tight regulatory system will require knowledge of
the relative transcriptional and translational efficiencies of these genes, as well as the half-lives
of their protein products.
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The ability of D. radiodurans to survive extreme damage to its DNA requires that it be able
to cleanse itself efficiently of the reactive oxygen radicals that result from ionizing and UV
radiation, desiccation, and oxidative stress agents (25). In addition, D. radiodurans must quickly
degrade, export, or recycle damaged DNA components to prevent mutations. As a uric acid
responsive transcriptional regulator, HucR is a likely candidate in contributing in both capacities.
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